VIR Flashcards

(375 cards)

0
Q

MELD

A

3m survival in pts post TIPS and to prioritize pts for transplant

Based on Cr, Tbili, INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Barcelona-Clınic Liver Cancer (BCLC) staging

1) 3 components?
2) How is is scored and what is the treatment for each score?
3) Survival for each score?

A

1) 3 Components:
- Child Pugh - BA-PEA
- Performance status - ECOG 0 to 5
- Tumor characteristics (size, #, vascular invasion,
MPV-HV gradient)

2) Scored 0, A, B, C, D:
- 0 & A: Early: curative tx (surgery/transplant/RFA)
- B: Intermediate: multinodular tx with TACE,
- C: Advanced: vascular invasive/metastatic, tx
with Sorafenib
- D: Terminal: symptomatic tx.

3) Survival
- 0 & A: 36m
- B: 16m
- C: 6m
- D: 1m

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rx for arterial stenting

A

Maggie does 3 months on everyone. Longer if CLI, poor runoff, < 7 mm stent, stent graft). Procedural loading dose of 300mg or start 24h before with daily dose 75 mg qd and lifelong ASA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

EASL: European Association for the Study of the Liver

A

Looks at enhancement to evaluate tumor necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Amplatzer sizing for arteries and veins

A

Arteties: 20-40% upsize

Veins: double the size of the plug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bronchial artery location?

N4

A

2L, 1R at T5-6

Just do bronchials with particles > 250u to minimize risk of tissue necrosis and decrease risk to spinal arteries.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Leaking Gtube

A

1) PPI 4-6w
2) Low profile to decrease torque
3) Wound care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Venous malformations embo agent

A

Ethanol (1 ml/kg)
Max injection rate 0.1cc/kg/5 min (vs Sotradecol which is 0.5cc/kg/5 min)

Can also use for cysts

Sotrodecol can also be used. May be more mild than alcohol when lesion superficial.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

LM embo agent

A

Doxycycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

UAE vs. Myomectomy in pregnancy

A

Similar pregnancy and complication rates, but higher miscarriage rates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Endovascular treatment of BtK CTO

A

Start 014 hydrophilic and then increase to larger stiffer wire if unable to cross.

Once CTO crossed switch to stiffer support wire.

Tx with angioplasty or atherecromy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Transplant criteria

A

3/5
4.5/6.5

Milan: transplant eligible if single tumor < 5 cm or up to 3, each smaller than 3 cm.

UCSF: transplant eligible if single tumor < 6.5 cm or up to 3, each smaller than 4.5 cm - with total diameter not exceeding 8 cm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Requirements for surgical rsxn in HCC pts? - only 10% pt eligible!

ECOG?
CP?
Lesion size?
PVHV Gradient?

A
  • ECOG 0
  • Child Pugh A
  • Single lesion < 2 cm
  • PVHV gradient < 10
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

RFA of HCC results most favorable with tumor size less than….?

A

3 cm

Note, for lesions < 2 cm, outcomes similar to surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Heat sink in RFA and cold sink in cryo most likely to occur when tumor abuts vessel of what size?

A

> 3 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

TACE survival benefit?

A

Two landmark prospective randomized trials demonstrated IMPROVED OVERALL SURVIVAL FOR TACE COMPARED WITH BEST SUPPORTIVE CARE in patients with HCC and preserved liver function (level IA evidence).

Lo: patients treated with TACE had 1-, 2-, and 3-year survival rates of 57%, 31%, and 26%, respectively, compared with 32%, 11%, and 3% in controls.

Llovet: trial stopped early when sequential inspection demonstrated that TACE had a significantly improved survival compared with conservative tx. One and 2-year survival rates for chemoembolization were 75% and 50%, respectively, compared with 63% and 27% for the control group.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When is TACE considered first line?

A
  • Intermediate stage (BCLC B) dz - large or multi nodular HCC with:
    a) relatively preserved liver function (Child Pugh A & B),
    b) absence of cancer related symptoms (ECOG 0),
    c) no evidence of vascular invasion or extrahepatic spread.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Criteria: Severe limb ischemia

A

1) rest pain
2) ulceration
3) gangrene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

VIBRANT Trial

A

VIABAHN endograft vs. BMS in tx of complex SFA dz.

No difference in patency rates noted. However, graft was the old Viabhan. Now, there is heparin bonding and contoured edges.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Primary patency

A

Exempt from restenosis of the target lesion during follow-up.

NO RESTENOSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Primary assisted patency

A

Patency of the target lesion following endovascular reintervention at the site of a symptomatic restenosis.

PATENCY OF SYMPTOMATIC RESTENOSIS AFTER INTERVENTION

Situation whereby patency is never lost but is maintained by prophylactic intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Secondary patency

A

Patency of the target lesion after treatment of a (re)occlusion of the index lesion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Covered vs uncovered biliary stents?

A

Krokidis: Bard eLuminexx BMS vs. Gore Viabil for palliation of malignant jaundice caused by pancreatic head masses (adeno/cholangio).

Covered stents do not afford survival benefit but demonstrate superior primary patency rates, decreased tumor in-growth, improved pt QOL and requires fewer re-interventions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

VIASTAR Trial

A

Heparin-bonded covered stents (Viabhahn) vs. sE BMS in long fem pop lesions ≥20 cm.

Heparin bonded stent grafts demonstrated significant clinical and patency benefits.

This was update to VIBRANT trial.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Dake's Zilver PTX (Paclitaxil) studies (fempop)
DES superior to BMS with respect to patency and freedom from TLR. Clinical metrics (The Rutherford classification, ABI, and WIQ scores) improved in both the DES and PTA groups from pre-procedure to 2 years with no significant differences between the groups. Patients in the provisional DES group also sustained greater clinical benefit through 2 years compared with the provisional BMS group (83.9% vs. 68.4%). Provisional group had stents placed after acute PTA failure.
25
RESILIENT trial
Self expanding BMS vs PTA as primary treatment of moderate-length lesions in the SFA and proximal popliteal artery. BMS associated with better angiographic results and improved clinical outcomes compared vs PTA. Rate of stent fracture was low and was not associated with any adverse clinical sequelae.
26
ATTRACT Trial
Background: The management of acute DVT by medical therapy with anticoagulation has long been supported by evidence-based clinical practice guidelines outlined in the American College of Chest Physicians supplement. Early thrombus removal in patients with iliofemoral DVT has been reported to lead to improved venous valve function, improved quality of life, and decreased incidence of postthrombotic syndrome over anticoagulation alone. The ATTRACT trial will randomize patients to medical management with standard anticoagulation versus catheter-directed thrombolysis in addition to standard anticoagulation after stratification to iliofemoral versus femoropopliteal DVT in order to determine the primary outcome of postthrombotic syndrome over a 24-month follow-up. Assessed clinical outcomes include 2-year PTS rates, health-related quality of life, relief of pain and swelling, safety, and cost effectiveness.
27
COBEST TRIAL
Covered vs SE BMSs stents for the treatment of aortoiliac occlusive disease. Result: in pts with aorta iliac occlusive disease, there is decreased restenosis and occlusion with covered stents vs BMS at 12 & 18 months.
28
Clinical categories of acute limb ischemia (I, IIa, IIb, III)?
I, “Viable": intact motor/sensory; audible arterial and venous Doppler in ankles. IIA, “Marginally Threatened”: no sensory loss or limited to the toes; inaudible ankle arterial Doppler (motor and venous Doppler WNL) IIB, “Immediately Threatened": sensory loss above level of toes; detectable muscle weakness; probable continuous rest pain. III, “Irreversible”: profound motor and sensory loss; inaudible arterial and venous Doppler. Can still occasionally be treated if able to treat within 1-2 hours of onset (emboli event). SENSORY FIRST TO GO.
29
Treatment for each clinical categories of acute limb ischemia?
I, “Viable": - Heparin and obs if multiple co-morbidities; - Endovascular (CDT & mech thrombectomy + tx of underlying lesion) if few co-morbidities. IIA, “Marginally Threatened”: Endovascular (CDT & mech thrombectomy + tx of underlying lesion). IIB, “Immediately Threatened": Surgery or Endovascular depending on available capabilities. Note, perceptible improvement in limb perfusion with CDT typically occurs well before complete thrombus removal and angiographic demonstration of a widely patent arterial lumen. III, “Irreversible”: Amputation. Co-morbidities generally treated first.
30
Acute arterial occlusion - embolism versus thrombosis?
Embolism (75%): dramatic, immediate onset. Heart is most common source of emboli. Thrombosis (25%): gradual with collateral formation. Progressive ATH with ultimate plaque rupture and thrombosis.
31
Pulmonary Angiogram
1) Access 2) 9 sheath (use 45 cm is support needed) 3) 7 Fr Van Aman catheter to MPA & RPA 4) Rosen inserted through Van Amen 5) Van Aman exchanged for a 7 Fr White Lumax catheter system (7 Fr guide sheath and 5 Fr Tapered tip catheter like a Berenstein) which is used to sub select with either a Bentson or Glidewire or the 5 Fr tapered tip catheter. 6) Intervention then performed. Coiling, plugs and glue can be performed through the White Set. Alternatively, the tapered tip catheter in the white set can be exchanged for a 5 Fr pigtail for mechanical thrombolysis and tPA.
32
3 PE Biomarkers
1) Ti: seen in submissive and massive when there is enough RV stain to cause leakage from myocytes. 2) BNP: Elevated with ventricular stretching as with PE, CHF and other causes of pulmonary HTN. 3) d-Dimer: measures a fibrin derivative. Superior sensitivity but alone is non specific. Positive also in pts with CA, infection, injury, inflammation. When d-Dimer negative in setting of low protest probability, imaging not necessary.
33
Massive PE requires:
SBP < 90 mmHg (signifies cardiogenic shock)
34
Treatment of massive PE
1) Heparin 2) Systemic thrombolysis: 100 mg IV tPA over 2 hours. Must have no contraindications. Still carries 20% risk of major hemorrhage and 3-5% risk hemorrhagic stroke. 3) CDT with no or low-dose tPA (< 30 mg): when contraindications to systemic tPA or insufficient time to infuse full dose IV thrombolytics. Rate of major complications only 2.4% b
35
Heparin dose? ACT baseline? Goal post Heparin? When can sheaths be removed?
50-100 U/kg or 3000 U for small women, 5000 U for small man. ACT checked at baseline (nl 80-120s) with goal of 2.5x increase. Sheaths removed when ACT at baseline or < 200s.
36
LMWH mechanism, half life and monitoring?
Inactivates factor Xa. 5-7 hours. Can monitor anti-Xa levels.
37
Heparin half life?
1.5 hours
38
Platelet transfusions. One apheresis unit (a six pack) raises platelet levels by?
~ 30,000
39
Protamine reversal of heparin?
1.0 - 1.5 mg protamine sulfate IV for every 100 IU of ACTIVE heparin, not to exceed 50 mg. OR As a general rule, 10 mg of protamine will neutralize 1000 units of heparin; the dose should be halved every 30 minutes after heparin administration. Example: Start with 50 mg protamine if 5000U Heparin given <15m, give 50 mg. At 30m, halve dose to 25 mg. At 60m, halve dose to 12.5 mg. At 90m, halve dose to 6.25 mg.
40
Endovascular techniques for massive PE.
1) Catheter directed mechanical fragmentation: rotating pigtail fragmentation (can result in distal embolization and elevation of PAP requiring adjunctive aspiration thrombectomy to complete tx), mechanical devices (just know Angiojet can cause bradycardia and heart block and and has a black box warning). 2) Intraclot administration of tPA. Note if tPA given proximal to thrombus, currents will direct it away from the clot.
41
Submissive PE definition?
PE causing right heart strain without systemic hypotension. Right heart strain can be demonstrated via cardiac Biomarkers, EKG findings (ie. T wave inversions in leads 1-4), clinical findings (JVD), imaging findings (RV:LV > .9, tricuspid regurg).
42
Treatment of submissive PE?
1) Systemic tPA (100 mg/2 hours): off label for submissive PE; decrease in hospital death, clinical deterioration and development of chronic pulmonary artery HTN in patients with submissive PE treated with systemic tPA vs heparin alone. 2) Catheter placement and overnight thrombolytic infusion (total dose 1-2 mg/hr or 0.5-1 mg/hr each side) as mechanical debulking may not be necessary given hemodynamic stability.
43
Biliary sepsis
1gm Ampicillin 80mg Gentamicin (check renal fx) 500 mg Flagyl * Then get ID approval for more long term treatment. If outpatient and just a fever, can give 10 days cipro 500mg BID.
44
Non functioning central venous catheter?
1) 4 mg tPA in 50 cc NS over 1 hour 2) 4 mg in 10 cc NS to dwell 3) Venogram to look for sheath/kink, strip it
45
Non draining tube management?
4 mg tPA/20 cc NS for 2-4 hours, roll pt, then open.
46
Labs to order for suspected chylous leak? TLC
Triglycerides Lymphocytes Cholesterol
47
Hiccups?
Reglan 10mg QID Or Thorazine 10mg TID (hallucinations)
48
Skin burn from EtOH embolization?
Ice and Bactroban ointment.
49
UAE Toradol?
30 mg IV q6h
50
Best HD access?
AVFs: best patency rates although PTFE grafts outnumber AVFs 2:1.
51
The Kidney Disease Outcomes Quality Initiative KDOQI HD catheter management guidelines
Tunneled: 1) Exit site infection with (-)BCx, (-) systemic, (-) tunnel d/c: Topical Abx and local care or oral Abx. If tunnel drainage, Cx and administer IV Abx based on C&S. 2) Bacteremia in stable pt: Overwire exchange and retunnel. 3) Catheter related bacteremia, unstable pt: Remove. 3) Catheter related bacteremia in patient who is afebrile w/in 48h and is clinically stable: can attempt catheter salvage with interdialytic Abx lock solution and 3w IV Abx. Temporary: Remove if catheter related bacteremia.
52
1) First line treatment of central vein stenosis when treating AVFs and AVGs? 2) When to stent?
1) PTA 2) Elastic central vein stenosis that does not respond to larger balloon or prolonged PTA or if stenosis recurs in 3 months.
53
Advantage of renal bx?
- Determine RCC subtype. - Dx lipid poor AML. - Improved efficacy calculation for academic purposes.
54
Cryoablation ice ball
The edges of the visible ice ball represents the 0 degree isotherm and is not lethal. As such the margins of the ice ball should extend 5-6 mm (optimal 1 cm) beyond the margins of the tumor. This ensures that the tumor is frozen to at least -25 degrees Celsius.
55
Renal cryo ablation protocol?
10 minute freeze 8 minute thaw 10 minute refreeze
56
Patients in whom preoperative (pre-cryo) embolization of RCC is of benefit?
- Elderly or those with increased bleeding risk. | - Large masses requiring multiple cryo probes.
57
Complications after percutaneous renal ablation?
TOP 3: Hemorrhage, Nerve Injury, Hematuria 1) Hemorrhage is MC (can restart anticoag 2 days after RFA but Coumadin should be held for 2 weeks due to risk of delayed bleeding - bridge with Lovenox) 2) Nerve Injury (in 15%): intercostal and genito-femoral. Usu self limiting. 3) Hematuria (10-20%): Self limiting. Make sure pt can void. Bladder irrigation prn. 4) PTX when the probes cross the pleura. 5) Urethral injury (can place double-J pre procedure for 4-6 weeks). 6) Adrenal crisis if the lesion is close to the adrenals: Premed with alpha and beta blockers for at lease a week.
58
Post renal cryo ablation follow up?
Contrast enhanced MRI or CT at 1, 3, 6, 12, 18, and 24 months, and annually thereafter. 15-20% of cases show some persistent, peripheral enhancement in the ablation zone without residual tumor in the first few months; nodular or central enhancement or an increased size of the lesion is not normal and suggests residual or recurrent tumor, potentially requiring retreatment.
59
Efficacy of renal cryoablation?
Comparable to surgery with early stage disease.
60
Rigors treatment?
Demerol 25 mg slow IV push every 20 minutes until controlled. Up to 2 doses then try Dilaudid. Dilaudid 1 mg IV
61
Radial access premeds?
​NV-H Intra-arterial: 200 mcg Nitroglycerin, 2.5 mg Verapamil, 3000 units Heparin given directly into the sheath post placement. EMLA cream 30 to 60 min before procedure.
62
Modified Allen Test?
1) Patient instructed to clench fist for 30 seconds. 2) Examiner then compresses the RADIAL and ULNAR arteries simultaneously. 3) Patient asked to open 4) ULNAR artery is released. 5) Time needed for maximal palmar blush to return is recorded. Normal time for return of palmar blush: 5–10 seconds is typically considered normal (ie, a positive modified Allen test) and indicates adequate collateral circulation.
63
Most common uterine artery anatomy?
Often first branch off anterior division or may share common trunk with the superior vesicle artery. Had descending, transverse and ascending segments which allows it to be distinguished from the SVA or inferior gluteal aa which descend distally.
64
BRTO: Balloon-occluded retrograde transvenous obliteration of gastric varices. 1) Which varices have a higher flow rate and mortality rate - esophageal or gastric? 2) What are the target porto-systemic gradients post TIPSS for refractory ascites and esophageal varices? 3) Does the target gradient for esophageal varices apply to gastric varices? 4) How is BRTO performed?
1) Gastric varices have a higher flow rate and mortality vs. esophageal varices. 2) < 8 mmHg for refractory ascites; < 12 mmHg for esophageal varices. 3) No, gastric varices still demonstrate a high rate of bleeding post TIPSS even at pressure gradients < 12 mm Hg. 4) Venous access into the gastro-renal shunt via the L renal and adrenal veins. Occlusion of the outflow veins using an occlusion balloon followed by the injection of a sclerosing agent directly into the varix endovascularly.
65
Treatment of arterial spasm?
Inject saline or 100 ug nitroglycerine.
66
RENOVA Study: A randomized controlled comparison of stent grafts vs. PTA for the treatment of AVG venous anasatamotic stenoses.
At 2 years: stent grafts proved as safe as balloon angioplasty and more effective in terms of treatment area and overall access patency (decreased need for repeat intervention and longer time to subsequent intervention).
67
Artery of Adamkiewicz? 1) Most commonly located on what side? 2) Most commonly located at what level? 3) Arise from what vessel(s)? 4) Average diameter?
1) ~75% on the left 2) ~75% at level of 9th-12th intecostal artery 3) From the radiculomedullary branch of the posterior branch of the intercostal or lumbar arteries. 4) 1mm NOTE: Bronchials most commonly have have 2L, 1R and occur at T5-6.
68
Roadmap imaging
The superimposition of a stored image over a live fluoroscopic image.
69
Waldman loop technique
Technique to catheterize ipsilateral uterine artery. GS uses a 5F Cobra 2 glide catheter.
71
Warfarin Hold Parameters 1) High risk (TIPSS, renal bx, RFA, new neph/bili tubes, arterial access w/ >7F sheath)? 2) Low risk (venous interventions, IVC filter, tube changes)? 3) Bridge? 4) When to resume?
1) 5d to INR
72
ASA Hold Parameters 1) High risk (TIPSS, renal bx, RFA, new neph/bili tubes, arterial access w/ >7F sheath)? 2) Low risk (venous interventions, IVC filter, tube changes)?
1) 5 days | 2) Not held
73
Heparin Hold Parameters 1) High risk (TIPSS, renal bx, RFA, new neph/bili tubes, arterial access w/ >7F sheath)? 2) Low risk (venous interventions, IVC filter, tube changes)?
1) 2-4 hrs and check aPTT to goal <1.5x | 2) On call to IR
74
LMWH Hold Parameters 1) High risk (TIPSS, renal bx, RFA, new neph/bili tubes, arterial access w/ >7F sheath)? 2) Low risk (venous interventions, IVC filter, tube changes)? 3) When to resume (low risk vs high risk procedures?
1) 2 doses or 24h 2) 1 dose or 12 hours 3) Immediately with lowest risk procedures once hemostasis achieved. 24-72 hours for highest risk procedures.
75
Plavix Hold Parameters?
5d in general. If high priority low risk (venous interventions, IVC filter, tube changes), can hold 0-5d.
76
Fondaparinux/Arixtra (SC) Hold Parameters 1) High risk (TIPSS, renal bx, RFA, new neph/bili tubes, arterial access w/ >7F sheath)? 2) Low risk (venous interventions, IVC filter, tube changes)?
1) 2 to 5 days based on CrCl (2-3d if CrCl > 50, 3-5d if
77
NSAID Hold Parameters 1) High risk (TIPSS, renal bx, RFA, new neph/bili tubes, arterial access w/ >7F sheath)? 2) Low risk (venous interventions, IVC filter, tube changes)?
1) Based on NSAID half-life. Ibuprofen (short t 1/2) held for 24 hours). Naproxen & Celecoxib (intermediate t 1/2) held 2-3 days). Meloxicam (long t 1/2) held 10d. 2) Not held
78
Bivalirudin (drip; Angiomax) Hold Parameters 1) High risk (TIPSS, renal bx, RFA, new neph/bili tubes, arterial access w/ >7F sheath)? 2) Low risk (venous interventions, IVC filter, tube changes)?
1) Defer until off medication. If emergent, try and hold for 2-3h for CrCl > 50, 3-5h for CrCl
79
Integrilin (drip) Hold Parameters 1) High risk (TIPSS, renal bx, RFA, new neph/bili tubes, arterial access w/ >7F sheath)? 2) Low risk (venous interventions, IVC filter, tube changes)?
1) 4 hours | 2) Held until just before punctur
80
Glue Steps?
1) Flush microcatheter with D5W 2) Administer lipiodol:glue suspension (we used 3:1 for renal paeudoaneurysm - more glue = more viscous/thicker) 3) Follow with D5W flush 4) Remove microcatheter
81
May Thurner and CTVO. 1) Stent Type? 2) Anticoagulation?
1) SE BMS (e-Luminexx to 14 mm, Zilver Vena to 16 mm). 2) No consensus. - JHH: one month if no DVT. - (+)DVT, 3 month recommended provoked tx. - Chronic DVT or aggressive stenting (ie. to lesser troch): AC for up to 1 year may be required.
82
Stents
Self-expanding stents: SMART (Cordis), eLuminexx (Bard), Zilver PTX drug eluting (Cook), Zilver Vena (up to 16 mm diameter), Life stent (Bard), Wallstent (Boston Scientific). Self-expanding stent grafts: Viabahn (Gore), Fluency (Bard), Wallgraft (Boston Scientific). Balloon-expandable stents: Palmaz (Cordis), Express (Boston Scientific) Balloon-expandable stent grafts: I-cast (Atrium Medical)
82
Left PVE is rarely indicated. Why?
Because even with an extended L hepatectomy (2,3,4,5,8) and caudate lobectomy, we are still left with a FLR of 33%. Future Liver Remnant
83
Portal vein embolization: How much liver must remain post resection?
20% if normal function to 60% with cirrhosis.
85
PVE Approaches?
Contralateral (access L to embo R): risks damaging FLR and thrombosing good PV. Ipsilateral approach: access R to embo R.
85
PVE embolic agents?
1) n-butyl cyanoacrylate (NBCA) and lipiodol, 2) Fibrin glue, 3) Ethanol, 4) Microparticles such as PVA or trisacryl gelatin.
86
Portal vein embolization 1) What is the ideal kinetic growth rate? 2) When is followup imaging performed?
1) FLR growth rate > 2%/wk post embolization associated with lower complication rates than <2%. 2) 4 weeks post PVE
88
Glue: n-Butyl cyanoacrylate monomer (nBCA) Ingredients?
- n-BCA (glue) w/ piercing cap - Tantalum Powder (gray metallic to opacity) - Ethiodized oil
89
Acute VTE tx?
3 months AC for provoked DVT - Initiation with Heparin, LMWH or Fondaparinux (days 1-7, minimum 5 days or INR > 2.0 for 24h) - Acute phase tx: Oral AC (d1-m3) Then stop, or Secondary Prevention phase: targets new clot. Only needed if high enough risk for new clot formation.
90
Management of isolated distal DVT (below pop) without iliofemoral clot.
- Serial US (qw x 2w) if no severe sxs. OR - Anti coagulation if severe sxs or risk factors (Dd, CA, prior clot)
91
Upper extremity DVT 1) When is anticoagulation indicated? 2) For what duration?
1) When clot is proximal to the axillary vein? 2) Same as LE DVT - minimum duration 3m. If catheter-associated (ie. PICC): Can AC for 1 wk to stabilize clot, then remove. Or can leave in place during AC tx if access required.
91
Warfarin dosing?
Choose initiation dose: warfarindosing.org (complex calc)
92
IVC filter indications?
- AC contraindicated - Failed AC - Low CPR
94
AC duration for provoked DVT (in association with major surgery, trauma, immobilization, or pregnancy)? AC duration for unprovoked/idiopathic DVT?
1) 3 months | 2) Workup required with possible secondary prevention AC beyond 3 months.
94
DAT - Dual Antiplatelet Therapy.
ASA 81 mg qd | Plavix 75 mg qd
96
1) Drugs used in Dual Antiplatelet Therapy (DAT)? | 2) Plavix dosing?
1) ASA 81 mg qd AND Plavix 75 mg qd | 2) 300 mg procedural loading dose OR start 75 mg day prior
97
Biliary stents in the palliative of malignant jaundice - BMS vs. Stent Grafts (Viabil).
Covered stents don't influence patient survival but do demonstrate superior primary patency, decreased tumor in-growth and require fewer re-interventions, thereby affording a QOL.
97
Vertebroplasty
Injection of cement under high pressure into a VB compression fx.
98
Biliary Stents
- Wallflex (covered and uncovered with retrieval loop) - Viabil - E-Luminexx BMS (done x1)
99
Kyphoplasty
Injection of cement into a VB compression fx following ballooning of the fx.
100
AAA size threshold at which intervention is performed?
5 - 5.5 cm
101
Too narrow a BP cuff does what to pressure?
Falsely elevates it.
102
ABIs: - >1.4? - Normal? - Intermittent claudication? - Ischemic rest pain? - Impending tissue necrosis?
- >1.4: sig arterial wall Ca (DM, CRF) - Normal: 1 - Intermittent claudication: < 0.6 - Ischemic rest pain: < 0.4 - Impending tissue necrosis: < 0.1
103
Heavily calcified arteries can do what to pressures?
Elevate them.
104
Segmental limb pressures: 1) How many cuffs are used? 2) How much should the gradient drop between each level? 3) How much wide should the cuff be than the diameter of the limb at that level? 4) The proximal thigh cuff cannot always be 20% wider than the diameter of the proximal thigh. As such, the thigh pressure may be.....
1) 4 cuffs used - prox thigh, above knee, below knee and above malleolus. 2) Gradient should drop no more than 10-12 mm between each level. 3) Cuffs should be 20% wider than diameter of limb at that level. 4) Falsely elevated.
105
When performing segmental pressures, can diminished proximal pressures mask gradients that exist further down the leg?
Yes
106
1) Ddx arterial ischemia? | 2) Clinical characteristics of spinal stenosis?
1) DDx - PAD - Venous claudication - Spinal stenosis - Neurogenic claudication - Chronic exercise induced compartment syndrome 2) Pain with standing and coughing, relieved by leaning forward, takes a long tim to abate post cessation of exercise.
107
T/F: Only exercise induced muscular pain of the calf, thigh and buttock, relieved by a few minutes rest and reproduced with walking can be confidently improved by LE revascularization?
True
108
T/F: Almost all patients with intermittent claudication have diminished or absent LE pulses?
True
109
Normal LE Doppler waveforms?
Triphasic with brisk systolic upstroke, reverse flow component early in diastole and low end-diastolic forward flow. This reflects high end organ resistance to flow in the resting extremity.
110
Criteria for a positive exercise treadmill test (which diagnoses arterial insufficiency)?
1) A decrease in the absolute ankle pressure of 20mm Hg or 20% Or 2) A decrease in the ABI of 0.2 in the symptomatic extremity after exercise testing.
112
LE Doppler waveform with increasing proximal stenosis?
1) Reverse flow component is lost first. 2) Rise in systolic upstroke decreases. 3) The amplitude of the waveform decreases. 4) Diastolic flow increases relative to the systolic flow.
112
50% reduction in arterial diameter is equivalent to surface area reduction of....
75%
113
What is Duplex US?
Combines grey scale (B-mode) and color Doppler. B-mode allows plaque visualization and localization of the artery which permits precise placement of the Doppler sample volume at a known angle (60 degrees best) to the artery being examined. Knowing the angle allows for calculation of frequently shifts, velocities and degree of stenoses.
114
Duplex criteria for peripheral artery stenosis?
Spectral broadening and elevated PSVs.
115
Coumadin, ASA, Plavix hold?
Generally 5 days. Can be adjusted based on risk of procedure and need.
116
INPACT SFA Trial: Compared the InPact drug coated balloon (Paclitaxel) to standard PTA.
DCB: - Fewer TLRs vs PTA - Better 12m primary patency (82% vs 52% w PTA)
118
Lysis cases: sheath management.
Sheaths should receive continuous infusion of NS at 30 mL/hour to prevent sheaths from clotting. Heperanized saline should be given through infusion catheters if tPA is stopped for any reason.
119
Joint Injections: 1) What anesthetic can be injected to proved pain is coming from within the joint? 2) Is Bupivicaine a safe alternative? 3) Is Bicarbonate safe to mix with anesthetic?
1) Use Ropivicaine (longer acting) or Lidocaine ( shorter acting) to confirm location. 2) No, Bupivacaine is chondrotoxic. 3) Bicarbonate will precipitate.
120
Meds post radioembolization?
Oxycodone Zofran prn Pantoprozole 40 mg 4 weeks
121
Tx options for each NSCLC stage (I-IV)?
Stage 1 & 2: surgery Stage 3a: surgery, chemo & RT Stage 3b: chemo & RT Stage 4: palliative chemo Surgery dropped first then RT
121
Thermal ablation of Small Cell Lung Cancer?
Has not been investigated but could potentially be used to treat limited peripheral Stage 1 SCLC.
122
Indications for percutaneous thermal ablation in NSCLC?
Stage 1 & 2 NSCLC in inoperable candidates (do not meet pulmonary criteria for lobar or sublobar resection - FEV & DLCO > 60%).
123
For all pulmonary malignancies, both primary and secondary, percutaneous thermal ablation can be thought of as a reasonable alternative in pts who are medically or surgically inoperable or who have residual or recurrant disease despite other treatments.
True
124
Indication for thermal metastasectomy?
1) Non surgical candidates | 2) Pts with recurrent or residual disease after surgery, chemo or RT.
125
Lung tumor characteristics that are favorable for thermal ablation?
1) Solitary 2) Completely intra-parenchymal 3) < or equal to 3 cm (best rate of necrosis - else use multiple probes) Also: < 6 lesions in the case of multifocal disease, no continuity with the hilum or vital mediastinal structures, such as the trachea, esophagus, heart, aorta, and great arteries.
126
RF ablation margin goal in lungs?
At least 5 mm rim of ground glass around lesion through 1 cm+ is preferred.
127
How many grounding pads are required with RFA.
At least 1. 2 if multiple probes.
128
Advantages and disadvantages of microwave ablation?
Advantages: 1) No grounding pads/skin burns, 2) No nerve pain, 3) Quicker (probes heat faster), 4) Less heat sink (probes heat faster). Disadvantages: 1) Higher cost, 2) Less predictable ablation pattern, 3) Interference with PMs and AICDs (will need cardiology to reprogram/disable or externally pace)
129
Multiple RFA probe instructions for use.
Electrodes should be placed no further than 2 cm apart and no further than 1 cm from the margin of the tumor (on the inside). Kelvin ablation article pg 242 fig 2.
130
Pain during RFA of the lung due to?
Stimulation of the intercostal nerves.
131
Right gastric artery origin
Proper hepatic aa (post GDA) Less commonly the common hepatic.
132
Compartment syndrome: 1) Usually seen in setting of prolonged ischemia lasting how long? 2) Clinical course? 3) Treatment?
1) > 6h 2) Patients initially improve post intervention but a few hours later deteriorate 3) Fasciotomy
133
Acute limb ischemia 6Ps
``` 6 Ps Pain Pallor Parenthesis Paralysis Poikilothermia (impaired temp regulation) Pulselessness ```
134
Claudication characteristics
Universally reproducible: occurs when walking X distance (vs OA pts have good and bad days) Relieved by rest: not necessarily sitting (as seen with spinal stenosis, sitting alleviates pain) Pain located within muscular bed, not joint.
135
First line therapy for claudication after exercise?
Smoking cessation Can improve walking distance and decrease progression to rest pain. Also decreases cardiac and cerebrovascular related mortality.
137
First line therapy for claudication after exercise?
Smoking cessation: Can improve walking distance and decrease progression to rest pain. Also decreases cardiac and cerebrovascular related mortality.
137
Interventions in claudicants: 1) How long after initial consultation should patients be seen to evaluate the efficacy of first line treatments (exercise, smoking cessation, med management)? 2) When are these first line treatments considered failures? 3) What is addressed first in an endovascular intervention on a claudicant?
1) 3-6 months 2) No clear guidelines to define failure. Based on lack of enough sx improvement or sx progression. 3) Inflow dz (ie. aortoiliac, femoral, SFA, profunda). Sxs will resolve in 85%. If poor response then address multilevel disease.
138
Med management of diabetic PAD patients
``` ABCD A: ASA B: Beta-blockers C: Cholesterol lowering meds D: Diabetes regimen ``` -target LDL t get into managing these meds.
140
The Rutherford classification: 1) What is it? 2) 3 components? 3) How many stages are there?
1) Clinical staging system for describing PAD. 2) Based on presence of claudication, rest pain, tissue loss. ``` 3) 7 Stages (0-6): Stage 0 – Asymptomatic Stage 1 – Mild claudication Stage 2 – Moderate claudication Stage 3 – Severe claudication Stage 4 – Rest pain Stage 5 – Ischemic ulceration not exceeding ulcer of the digits of the foot Stage 6 – Severe ischemic ulcers or frank gangrene ``` The distance that delineates mild, moderate and severe claudication is not specified in the Rutherford classification, but is mentioned in the Fontaine classification as 200 meters.
141
Target isotherms in cryoablation?
Fibrous tumors: best treated with the innermost -40 degree isotherm Water-containing tumors: can be treated using the -20 degree isotherm.
142
Lung Cryoablation: advantages and disadvantages?
Advantages: 1) Doesn't interference with PMs and AICDs 2) Lower subjective pain especially with subpleural or juxtapleural lesions 3) Spares collagenous structures and safer to nerves and bronchi Disadvantages: 1) Poor visualization of ice ball in lung 2) Increased risk of hemorrhage
143
1) Multiple cryo probe instructions for use? | 2) What isotherm is at the edge of the ice ball?
1) Electrodes should be placed no further than 2 cm apart and no further than 1 cm from the margin of the tumor (on the inside). 2) Edge of ice ball is 0 degree isotherm and does not kill tumor. Goal is to have edge of ice ball 5-10 mm beyond tumor margin, which represents -20 degree isotherm.
144
Lung cryoablation complications?
Cough, hemoptysis (62%), fever, and HTN. Pulmonary hemorrhage: Occurs during thaw cycle and on repositioning of the cryoprobe after the initial ablation cycle. Don't reposition. This is why Coumadin held for 2 weeks with cryo. Hemoptysis: seen with greater frequency in cryo than the other 2 modalities (62%). Typically, self-limiting. HTN: Unique to cryo. If preexisting HTN, ensure proper blood pressure control.
145
Complications of lung ablation?
- PTX - Post ablation syndrome - Pleural effusions - Hemothorax - Hemptysis - Nerve pain - Bronchopleural fistula PTX: Seen in 25%-35% of patients of RFA pts. 10%-20% of these patients require chest tube. Rates similar in microwave and lower with cryoablation. Postablation syndrome: mild fever, cough with rust colored sputum, chills, pain, nausea, and malaise. Can last 1-7 days. Can be seen in 36% of RF pts, 2% of microwave pts. Not seen in cryo pts. Tax with antipyretics, pain control, antitussives. Pleural effusion: seen in all 3 ablation modalities. Hemothorax less common but can be fatal. Hemoptysis: most common with cryoablation. Bronchopleural fistulas: seen in 0.6% of patients. Tx includes pleurodesis, endobronchial mgmt or surgical repair.
145
What is the risk of using conscious sedation in COPD patients?
Patients with COPD retain CO2. High CO2 normally stimulates breathing. This is blunted in COPD pts and instead low O2 drives respiration. When supplemental oxygen is given to a COPD pt, they are at risk for respiratory depression.
146
3 reasons to use GA in lung ablations?
1) Painful lesions (pleura, chest wall) 2) Can't lie flat 3) Lung disease/breathing problems
148
Post procedure care following thermal lung ablation.
Monitoring in PACU. CXR at 2 hours and 4 hours post procedure. D/C with Ibuprofen or other anti-inflammatory x5 days to reduce inflammation, pain, pleural effusions, and systemic inflammatory response. NOTE: postprocedural low-grade fever for 2-3 days is not uncommon. No air travel for 3 weeks as cabin pressure can predispose to PTX.
148
LIC: Localized intravascular coagulopathy 1) What is it? 2) Markers that indicate increased risk of hemorrhage? 3) Significance of a palpable phlebolith within a lesions? 4) Role of LMWH in LIC?
1) A coagulopathy associated with large and/or deep venous malformations that affect any location. 2) Lesions with elevated D-dimer and low fibrinogen levels (severe LIC) have the highest risk of hemorrhage. 3) Presence of a palpable phlebolith increases the risk of LIC. 4) LMWH can be used both to treat the pain caused by LIC and to prevent decompensation of severe LIC to DIC.
149
1) Can lung ablation be curative? 2) Survival rates at 1 year for early stage NSCLC following ablation? 3) Determinants of survival for lung mets? 4) Prognosis following ablative versus surgical metastasectomy?
1) Treatment can be curative with stage 1a and 1b NSCLC. 2) Range: 70-90% for early stage NSCLC or recurrent NSCLC and mets. 3) Determinants of survival for mets: - Baseline tumor size and type, - # of mets (pulmonary and non) and size - Control of the primary 4) Comprable.
150
Ampulla of Vater
Formed by the union of the pancreatic duct and the common bile duct. Above sphincter of oddi.
151
Retunneling a CVC.
1) Use a scapel to open the veno tommy site at the neck. 2) Grab the catheter with a clamp. 3) Cut catheter on tunnel side of clamp. 4) Stabilize venous side of device while removing over wire. 5) Place appropriately sized peel away sheath. 6) Remove tunneled portion of old catheter. 7) Retunnel new device.
152
HCC Screening: 1) Who? 2) What? 3) How frequently?
1) Who: All HBV pts and HCV patients with cirrhosis or fibrosis. 2) AFP and US 3) q6m
154
D-dimer
Fibrin degradation product present in the blood after a blood clot is degraded by fibrinolysis. Comprised of two crosslinked D fragments of the fibrin protein. Fibrinogen is fibrin precursor. It is decreased when the clotting cascade is activated.
155
PREPIC 1 & 2 study?
PREPIC 1: RCT in pts with proximal DVT showing that permanent vena cava filters reduced the incidence of PE but increased that of DVT at 2 and 8 years. The filters had no effect on survival. PREPIC 2: study of retrievable filters of which 92% were successfully retrieved at 3 months.
155
Internal iliac artery branches - posterior division?
Posterior division: Iliolumbar artery Lateral sacral artery Superior gluteal artery
157
Superficial abdominal wall arteries?
Inferior and superior EPIGASTRIC ARTERIES: arise from external iliac artery just above inguinal ligaments and ascends medially. Ascending branch of DEEP CIRCUMFLEX ILIAC ARTERY: arise from external iliac artery just above inguinal ligaments and ascends laterally.
158
Persistent sciatic artery 1) What is it? 2) Complications?
1) Continuation of the IAA into the thigh through the greater sciatic notch. It can be bilateral in up to 25% of cases. 2) Buttock aneurysms, ischemic embolic disease, early atherosclerosis.
159
1) Iliac PTA or Stenting. DAT Duration? | 2) Fempop PTA/stent. DAT Duration?
1) Iliac PTA or Stenting. DAT Duration? - Lifelong ECASA - 1m DAT for PTA or stent (>1m it poor inflow/outlfow, CLI.) **COBEST recommended minimum 1m. We did 3m DAT in COBEST kissing stent pt given signs of CLI and also because covered stents warrant longer AC. COBEST showed covered stents are better vs. BMS for TASC C/D Aortoiliac lesions in terms of patency and clinical outcomes. 2) Fempop PTA/stent. DAT Duration? - Lifelong ECASA - 1-3m with PTA or BMS if stent > 7 mm * **Consider >3 months if: - poor runoff (would apply to BK interventions) - CLI - long occlusion - Tasc C/D - High risk of stent fracture - > 6m with covered stent or with stent lumen <7 mm
160
RECIST (Response Evaluation Criteria In Solid Tumors):
Looks at max linear dimension of lesion on imaging to determine if a cancer patient responded to treatment (Categories: "respond", "stable" or "progression").
161
Contraindications for Trans Radial Access?
- Barbeau D waveform - Small radial artery - Pts w AVF or those nearing dialysis Barbeau D: loss of tracing without recovery within 2 minutes)
162
Fr to mm
3 Fr = 1 mm
163
Simplicity HTN-3 Trial results presented March 2014 (blinded, randomized, sham controlled study of renal-derivation for treatment resistant HTN.) 1) What were the Primary and Secondary endpoints? 2) Were the changes at 6m statistically significant? 3) What did the three year data released later in 2014 show?
1) Primary and secondary endpoints: In-office and 24h ambulatory BP at 6m. 2) No. SBP decreases were only in the order of 2 mmHg. 3) 3 year data showed a statistically significant decreases in SBP of -33 and DBP of -14 mmHg.
164
Pressures 1) RA/CVP 2) RV 3) PAP 4) LA 5) MAP
1) 2-6 mmHg 2) 25/5 3) 25/10, mean < 15 4) 4-12 5) 70-105 2-6, 25/5, 25/10, 4-12, 70-105
165
1) T/F: LHA can give rise to aberrant or accessory LGA. | 2) What must you differentiate when injecting the LHA?
1) True 2) Must differentiate gastric wall stain from tumor blush within the left hepatic lobe when injecting LHL vessels. Inadvertent delivery of chemo into an accessory LGA can cause gastric ulceration and necrosis.
166
Barbeau Test: 1) Define? 2) Steps? 3) Grades? 4) Which grade(s) is a contraindication to radial access?
1) Test used to assess dual hand circulation. Uses plethysmography (venous waveforms) and pulse ox to improve on the sensitivity of the modified Allen test. 2) Steps: 1) Pulse Ox placed on ipsilateral thumb and morphology of tracing noted. 2) examiner then occludes RADIAL aa, noting any change in tracing and SO2. 3) Grades Type A: no change in height of tracing even after 2 minutes. Type B: dampening of the pulse tracing. Type C: loss of tracing followed by recovery within 2 minutes, representing the recruitment of collaterals. Type D: loss of tracing without recovery within 2 minutes. 4) Only Type D is a contraindications to the procedure.
166
Caudate supply?
From the proximal segments of multiple hepatic arteries including the PHA, main LHA, main RHA.
167
1) Right gastric artery origin? 2) Course? 3) Inadvertent delivery of chemo can cause?
1) PHA, then LHA 2) Descends to PYLORUS then runs R to L along lesser curve to anastamose with the LGA. 3) GD ulceration and necrosis. Prophylactic embolization should be considered.
168
Two most common origins of the Inferior Phrenic Arteries?
Aorta, just above the celiac trunk. Directly from the celiac trunk as common trunk.
169
BASIL Trial: Bypass versus PTA in severe ischaemia of the leg (BASIL). 1) Define? 2) Outcomes?
1) Compared bypass-surgery to PTA in patients with severe infrainguinalischemic disease. Outcomes: Short-term: surgery is more expensive and has higher morbidity. Medium term: outcomes similar with respect to amputation-free survival, all- cause mortality and HRQL. Long term (>2y): surgery may be more durable.
170
Two most common hepatic aa variants?
1) Replaced RHA from the SMA (12%) - mC than accessory | 2) Replaced = Accessory LHA from the LGA (8%)
172
1) What is the middle hepatic artery? | 2) Origin?
1) A hilar artery that primarily supplies hepatic segment 4. 2) Arises from the RHA or LHA in 80%. **In livers w/ replaced LHA, the MHA originates from the RHA; in livers that had a replaced RHA, it originates from the LHA.
173
Hepatic falciform artery 1) Origin? 2) Course?
1) Arises as terminal branch from LHA or MHA. 2) Courses rightward over short segment, then leftward over longer segment towards the umbilicus. Communicates with branches of the IMA and Superior Epigastric Arteries.
173
Cystic artery origin?
RHA. Less commonly from the replaced/accessory RHA, the LHA, CHA, GDA. Has two branches.
174
Blood supply to the biliary tree?
From microscopic biliary plexus that is seldom visualized angiographically. Arises from corresponding hepatic artery branches. May dilate when supplying tumor invading the biliary tree or portal vein.
175
Cystic artery origin?
RHA. Less commonly from a replaced/accessory RHA, the LHA, CHA, GDA. Has two branches.
176
Pacreaticoduodenal arcade. 1) Origin? 2) Components? 3) Supplies? 4) Collateral pathways?
1) Arises from GDA branches, specifically the anterior superior pancreaticoduodenal artery and the posterior superior pancreaticoduodenal artery. 2) Components: - Anterior PDA: formed by anterior superior pancreaticoduodenal artery, the smaller of the two end branches of the GDA. - Posterior PDA: formed by posterior superior pancreaticoduodenal artery, usually the first branch off the GDA. 3) Supplies head of pancreas and duodenal C loop. 4) The most common collateral pathway from the SMA to the celiac. The two arcades either unite with the SMA via a separate inferior PDA given off by the SMA or end in a common inferior PDA.
178
Hepatic falciform ligament 1) What lobes does it divide? 2) What hap ends to the ligament in cirrhotics?
1) Runs along anterior margin of liver, dividing the LHL into medial and lateral segments. 2) In cirrhosis, the position of the ligament is shifted to the right pulling the artery with it.
179
Neff set vs Jeffrey set?
Both contain 15 cm access needles, 0.018 wires and three part introducers (inner stiffening cannula, introducer and outer sheath). Jeffrey: 8 Fr sheath can accommodate two 0.038 wires or a 5 Fr catheter and 0.018 wire. Neff: 6 Fr sheath and can accommodate one 0.038 wire or a 4 Fr catheter.
180
Denny set?
6 Fr peel away for a Hohn.
181
Dichroic notch?
Closing of the aortic valve.
182
AVFs 1) Several common AVFs in the arm? 2) Patency versus AVGs? 3) Drawbacks?
1) Radial-cephalic at wrist or brachial-antecube, cephalic or transposed basilic in upper arm. 2) 85% patency at 2y vs 50% grafts. 3) Require serval months to mature with 30% fail rate.
183
Normal AVF should have a continuous thrill at the anastamosis?
True
184
What does an AVF anastomotic thrill that occurs only during systole indicate?
An anastamotic stenosis.
185
What does a thrill along the course of the venous outflow of an AVF indicate?
A venous stenosis along the outflow limb.
186
A highly pulsatile AVF indicates what?
A central stenosis.
187
Once a venous stenosis has occurred in an AVF, recurrence requiring reintervention is seen in up to what percent of patients?
70%
188
A normal AVG should have a thrill at the arterial anastamosis and be only slightly pulsatile??
True
189
A bruit should be audible throughout an AVG?
True and the bruit becomes high pitched in the presence of a stenosis.
190
Are infections more common with AVFs or AVGs?
AVGs
191
1) Fistulgram procedure? 2) First step if intervention of AVF/AVG required? 3) Can devices be removed while patient is still on AC?
1) Venogram from access through micro-puncture directed towards venous outflow with imaging from the arterial anasatmosis to the RA. 2) Heparinize, then upsize to 5 or 6 Fr sheath over a 0.035 wire. 3) Yes. Apply gentle pressure or purse string.
192
What size balloon is used for PTA of an AVG venous anastamosis?
6-8 mm high pressure ballon depending on the known diameter of the graft.
193
What size balloon is used to treat venous stenosis in AVF outflow veins?
6-8 mm or whatever is appropriate visually.
194
What inflation technique can be used to minimize elastic recoil when performing venous PTA?
Multiple, slow, prolonged inflations.
195
What can be used when a venous lesion is resistant to PTA?
Cutting balloons.
196
1) How should venous lesions be treated during a fistulagram if they continue to recoil? 2) Should stents be used under the clavicle?
1) Stent them 2) No, due to fracture. Stent grafts improve patency of venous anastamotic stenosis in AVGs and may have advantages in central veins as well.
197
T/F: Arterial inflow lesions that cannot be dilated are treated with revision??
True
198
3) Is there an advantage to BMS over angioplasty in the treatment of venous outflow lesions and central venous lesions seen during fistulagram? 2) What is the primary patency of venous outflow and central venous lesions treated with PTA and BMS at 12 months? 3) What is the initial technical success rates of these procedures?
1) No 2) 30% at 12m 3) 90%
199
Acute complications of angioplasty and stent placement in dialysis access?
1) Acute thrombosis: responds to pharmachomechanic thrombectomy. 2) Dissection: prolonged balloon inflation or stent placement. 3) Rupture: 10-15 minutes of manual compression, else prolonged balloon inflation or stent placement across the site.
200
What is the most common cause of AVF/AVG thrombosis?
A stenotic lesion (must ID and address).
201
There is always a hard plug of white thrombus (platelets and fibrin) at the arterial anastamosis?
True
202
Why should forceful injection into a clotted AVF/AVG be avoided?
To prevent reflux of thrombus into the arterial circulation.
203
T/F: The venous system central to the dialysis access must be patent before starting a declot procedure? How do you determine this?
True. This can be determined by advancing a 5 Fr catheter centrally while injecting contrast until patent vessels are found.
204
Contraindications to a de-clotting procedure?
1) Patients with a suspected graft infection 2) Severely limited cardiac reserve (2/2 small PEs that result) 3) Patients with R to L shunts due to risk of paradoxical emboli. 4) Severe pulm HTN 5) Patients emergently requiring HD 6) Two declots in previous month - refer for revision 7) Clotted fistula with cannula site ulcer (eschar can rupture giving fatal hemorrhage) 8) Enlarged aneurysmal fistula with extensive clot burden (could give fatal PE) 9) Clotted fistula in presence of known Distal Hypoperfusion Ischemic Syndrome (DHIS - when high flow through AVF/AVG steals flow from hand).
205
Pharmacologic approaches to AVF/AVG declot?
Heparinize FIRST! Pulse spray: involves forcefully injecting tPA through two multi-sidehole catheters one in each direction. The jets fragment the clots while the tPA lyses. Progress checked via small contrast injections. Once adequate lysis, PTA venous anastamosis and pull plug through arterial. Lyses and wait: Insert small access in direction of venous outflow. Compress proximal and distal ends of access (arterial and venous anastamosis in graft or arterial anastamosis and distal venous outflow limb in AVF) while slowly injecting 5 mg tPA (5 ml). Wait 15-30 minutes. Upsize to 5-6 Fr sheaths in both directions in order to PTA venous anastamosis and pull plug through arterial. Angiojet
206
Leg veins: Reticular veins. 1) What are they and what do they drain? 2) Define pathological reticular veins? 3) T/F? The major saphenous trunks are usually not involved in patients with abnormal reticular veins and telangiectasias? 4) T/F: Pathologic reticular veins and telangiectasias are most commonly caused by incompetent reticular veins.
1) A network of veins parallel to skin surface (between the saphenous fascia and dermis) that drain the lower extremity skin and SQ tissue though saphenous tributaries or deep veins via perforators. 2) Dilated, nonpalpable, blue dermal veins,
207
Leg veins: GSV 1) Origin? 2) The GSV is bordered superficially and deep by what? 3) Location of the greater saphenous nerve in the calf? 4) Can you have true GSV duplication? 5) T/F: The great saphenous vein may penetrate the saphenous fascia at the level of the middle or distal thigh and become more superficial.
1) Arises from medial aspect of dorsal pedal venous arch, ascends anterior to the medial malleolus, crossing the tibia at the mid calf, passing posteromedial to the knee. Ascends medially in the thigh to perforate the deep fascia and join the common femoral vein 3 to 4 cm inferior and lateral to the pubic tubercle. 2) Bordered superficially by the saphenous fascia and deep by the muscular fascia. Lies within a subcompartment referred to as the 'Egyptian eye'. 3) Anterior to the GSV in the calf and may be injured by procedures extended into the calf. 4) Yes. It is identified by splitting of the vein into two channels, both lying on the muscular fascia and which later rejoin. Present in the thigh in 8% and in the calf in 25% of cases. 5) True. Lack of fascia support in these areas has been suggested as a cause of varicose veins, which most frequently occur above the level of the superficial fascia.
208
Leg veins: 1) Two main GSV tributaries in the calf? 2) Course of posterior arch (Leonardo’s vein)? 3) What does posterior arch (Leonardo’s vein) drain and why is this important?
1) Anterior branch (of the GSV or GSV proper) and the posterior arch (Leonardo’s vein) 2) Begins behind the medial malleolus and joins the GSV just distal to the knee. 3) Drains a network of medial ankle veins and is important in that the posterior tibial perforators join this vein rather than the main trunk of the great saphenous vein. Procedures directed toward the greater saphenous vein in the calf will not address these perforators.
209
Leg veins: Accessory GSV tributaries in the thigh?
Anterior and posterior accessory saphenous veins. Ascend parallel to the great saphenous vein, external to the saphenous fascia.
210
Leg veins: Venous drainage from the perineum and lower abdominal wall?
Superficial external pudendal, circumflex iliac, and epigastric veins. Join the GSV near the saphenofemoral junction.
211
Leg veins: Is there a valve at the GSV? Do fewer GSV valves predispose to varicose veins.
Yes, in 94%-100% of individuals. Yes, The main trunk of the GSV usually has at least six valves. Varicosed GSVs have slightly fewer valves although the relevance of this observation is unclear.
212
Leg veins: Small saphenous vein 1) Course? 2) Does the SSV have valves? 3) What nerve ascends lateral to the SSV?
1) Arises from the dorsal pedal arch, ascends posterior to the lateral malleolus ultimately joining the popliteal vein within 8 cm of the knee joint (~60%). In the remainder of pts, 20% join the GSV via the anterior and posterior accessory saphenous veins in the thigh and 20% join the deep venous system. 2) Yes, 7 to 10 closely spaced valves. 3) The sural nerve.
213
Leg veins: Vein of Giacomini?
A cranial extension of the small saphenous vein that ascends posteriorly in the thigh to communicate with the great saphenous vein through the posterior thigh circumflex vein.
214
Deep leg vein nomenclature?
The major deep veins of the lower extremity follow the course of the associated arteries and, with the exception of the femoral vein, are named accordingly. External iliac vein - inguinal ligament - common femoral vein - SFJ - femoral vein, popliteal vein, AT/PT/peroneal veins. The deep vein extending from the popliteal vein to the common femoral vein is now referred to as the femoral vein rather than the superficial femoral vein. The phrase ‘‘superficial femoral vein’’ has been abandoned in current nomenclature.
215
Leg veins: Perforating veins in the lower extremities. 1) Approximate #? 2) Direct vs. Indirect perforators? 3) Normal drainage direction of perforators? Exceptions? 4) 4 groups of calf perforators? 5) Linton's line? 6) Femoral canal perforators? Connect what to what?
1) Greater than 60 perforators between the ankle and the groin. 2) Direct: Empty into deep veins; Indirect: Empty into venous sinuses of the calf. 3) Superficial to deep via valve directed flow? Foot perforators which drain deep to superficial. 4) Calf perforators: 1. Paratibial perforators: connect GSV and PTV. 2. Posterior tibial perforators: connect post arch and PTV. 3. Lateral perforators. 4. Anterior perforators. The medial calf perforators, including the paratibial and posterior tibial perforators, are clinically most important. Eponyms Sherman, Boyd, Cockett no longer used. Many paratibial perforators may not be accessible with subfascial endoscopic perforator ligation unless the fascia between the superficial and deep posterior compartments is incised. 5. An ~3-cm wide imaginary lane ascending the medial calf along which the majority of the medial calf perforators (para and posterior) exist. 6. The perforators of the femoral canal (hunterian perforators) connect the GSV and the distal femoral or proximal popliteal vein. These perforators may give rise to medial thigh varicosities in the presence of a competent proximal great saphenous vein.
216
Leg veins: What are the muscular venous sinuses in the calf?
The muscular venous sinuses are the principal collecting system of the calf muscle pump. There are soleal and gastrocnemial intramuscular venous sinus networks which communicate with the PTV and pop.
217
CEAP Classification? A classification system for chronic venous disorders.
Clinical Etiology Anatomic distribution Pathophysiology 1) 7 Clinical disease classes based on objective signs from asymptomatic to active ulcers. C0: no visible or palpable signs of venous disease. C1: telangiectasies or reticular veins. C2: varicose veins. C3: edema. C4: skin changes without ulcerations. C4a: pigmentation and eczema (stasis dermatitis). C4b: lipodermatosclerosis and atrophie blanche. C5: healed venous ulcer. C6: active venous ulcer. S: symptoms including ache, pain, tightness, skin irritation, heaviness, muscle cramps, as well as other complaints attributable to venous dysfunction. A: asymptomatic. 2) Etiology: Congenital, Primary, or Secondary. Congenital causes include things like absent valves. Primary venous disorders are not associated with an identifiable mechanism of venous dysfunction (likely just degenerative). In contrast, secondary venous disorders result from an antecedent event, usually an episode of acute deep venous thrombosis (DVT). 3) Anatomic distribution: 18 venous segments. 4) Pathophysiology: whether related to reflux or obstruction.
218
Three causes of venous reflux or pathologic retrograde venous flow in the lower extremities?
- Degenerative processes (primary venous disease). - DVT (secondary venous disease). - Absent valves (congenital).
219
Varicose veins?
Dilated, palpable, tortuous, > 4 mm, do not discolor the overlying skin. The major saphenous trunks are often incompetent with varicose veins. vs. Reticular (Dilated, nonpalpable, blue dermal veins, < 4 mm, without saphenous trunk abnormalities).
220
Post Thrombotic Syndrome. 1) Seen in up to what % of patients with DVT? 2) Symptoms? 3) Pathophysiology? 4) Treatment?
1) 50% 2) Leg pain, heaviness, itching, swelling, redness, and ulcers (sores). Approximately 2/3 of pts with ulcers have multi segmental disease (involving the deep, superficial, and perforating veins). 3) DVT causes obstruction, pressure buildup, valve damage, resultant reflux, delayed venous filling and pooling of blood. 4) Treatment: anti coagulation, compression stockings, wound care.
221
What is lost first in the setting of advanced arterial disease - Motor or sensory?
Sensory
222
Child Pugh?
Used to assess the prognosis of chronic liver disease and cirrhosis. BA-PEA: - BIli - Ascites - PT - Encephalopathy - Albumin Points Class 1y surv 2y surv 5-6 A 100% 85% 7-9 B 81% 57% 10-15 C 45% 35%
223
Absolute contraindications to percutaneous lung ablation? Realtive?
ABSOLUTE: - Severe pulmonary HTN (> 40 mm Hg) - Acute PNA. RELATIVE: - Inability to lie flat and breath hold (use GA) - Coagulation disorders - Pacemakers/AICD - Prior pneumonectomy (OK if RAPID chest tube can be placed).
224
Bivalirudin, Integralin and Heparin hold parameters (drips)?
Heparin held on call for low/moderate. Integrilin stopped at time of puncture for low risk. Bival not held for lowest. All held 2-4 hours for highest risk procedures.
225
Complication specific to lung cryoablation?
HTN Also consider hemorrhage/hemoptysis as this also occurs with greater frequency in cryo patients.
226
Coils: 1) Types? 2) Size range? 3) Nomenclature? 4) Deployment steps?
1) Pushable and detachable. 2) 2-20 mm and straight for tiny vessels. 3) 35-5-10: will pass through a catheter that will accept a 0.035-inch guidewire; total extended length 5 cm; formed coil diameter will be 10 mm. 4) STEPS: - Position catheter. Advance guide or pusher wire to its tip to ensure stability. NOTE: micro catheters require a special pusher wire that is softer and flexible at the tip. - Load coil. Use hard end of pusher wire to advance coil well into catheter. Then flip wire and push with soft end. - Use smaller, shorter coils at the end to prevent covering vital branches.
227
Splenic Artery Embolization in the setting of trauma - In what patient population is the procedure performed in?
Individuals who are hemodynamically stable (unstable = surgery) and who meet one of three criteria: 1) Active extravasation on CT, 2) Grade 3-5 with decreasing H/H, 3) Visualized vascular injury (ie. paeudoaneurysm, AVF) and decreasing H/H. AGAIN: Extrav is not required for SAE. A grade 3 or higher injury is sufficient.
228
1) Under what scenarios do you definitely embolize during SA Angio? 2) What about patients with abnormal CT and normal angiography?
1) Active bleeding and vessel injury (pseudoaneurysm, AVF). 2) Some authors recommend embolization based empirically on the CT findings (ie. grade III to V injury without angiographic evidence of extra or vascular injury). Others base the embolization more on the angiographic findings and clinical evidence for active hemorrhage. Note, the discrepancy may be due to cessation of bleeding which can recur or vasospasm so don't rule out prophylactic embolization.
229
SAE technique?
1) Micropuncture access. 2) Celiac arteriogram through Sim 1 with particular attention paid to splenic artery and collaterals including the left gastric artery. 3) Splenic artery catheterization and splenic arteriogram. 4) Embolization - proximal vs distal.
230
Distal SAE: What is it? What embolics can be used?
1) Sub-selective embolization as close to the site of injury/etrav as possible utilizing a non high flow micro-catheter and wire combination (ie. Renegade STS catheter and Fathom 0.016). 2) Coils, glue, gelfoam, medium-size particles (300–500 μm).
231
Proximal splenic artery embolization: 1) Goal of procedure? 2) Splenic collaterals? 3) Where is coil pack placed? 4) What is the proximal SAE endpoint?
1) Decrease perfusion pressure of the spleen while allowing splenic flow via collateral pathways. 2) Short gastric arteries, pancreatic arteries, gastroepiploic arteries (from GDA and splenic), splenic capsular arteries. 3) Just distal to the dorsal pancreatic artery origin (typically in proximal 1/3 of splenic artery). This allows for perfusion of the spleen via the dorsal pancreatic–transverse pancreatic–arteria pancreatica magna–splenic artery pathway (pathway may be more evident immediately after the embolization). 4) Complete absence of opacification of the splenic artery distal to the coils.
232
Short gastric arteries?
5 - 7 small gastric arteries arising from end of splenic artery.
233
Is there a difference in the major complication rates requiring splenectomy (infection, infarction, and/or rebleeding) between proximal and distal SAE?
No
234
Advantages and disadvantages of proximal SAE? Efficacy of proximal vs. distal SAE?
Advantages? 1) Quicker 2) Less radiation 3) Less risk for infarction 4) Lower secondary splenectomy rate vs observation alone Disadvantage? 1) Can't re-intervene if coil pack placed proximally. Equal efficacy. As such, authors of this paper prefer to perform proximal embolization in trauma patients in nearly all circumstances.
235
Why do trauma physicians favor splenic preservation procedures (ie. SAE) in the setting of trauma?
Due to the risk of infection including fatal postsplenectomy sepsis.
236
Potential complications post SAE?
1) Infarct 2) Infection/abscess 3) Splenic artery dissection
237
Indications for IIA embolization?
1) Active extravasation 2) Vessel injury 2) Pelvic fractures with hemodynamic instability and no clear source for the hemorrhage.
238
Internal iliac artery embolization: Sub-selective embolization versus nonselective embolization of the more proximal internal iliac arteries. 1) When is proximal IIA Gelfoam embolization preferred? 2) Why is bilateral proximal IIA embolization frequently pursued? 3) When might more selective embolization be preferred? 4) Is the risk of recurrent bleeding higher following proximal or selective emboliztaion?
1) Multiple bleeding sites OR hemodynamically unstable patients with fxs in whom a source of bleeding cannot be ID'd. 2) Because of extensive collateral arterial circulation that is normally present within the pelvis. 3) In hemodynamically stable patients. 4) Selective embolization (occurring in 5-25%).
239
Three sources of bleeding secondary to pelvic fractures? Which is the most common?
Artery, vein, bone Venous!
240
Gelfoam endpoint in IIA embolization?
Administered to near-stagnation with resultant “pruned-tree” endpoint.
241
1) Is the incidence of short and long term complications higher in patients with pelvic fxs who undergo emergent IIA embolization versus those that do not undergo angiography at all? 2) What is the main side-effect seen in patients who undergo IIA embolization?
1) No 2) Buttock, thigh, and perineal paresthesia. Short term complications studied include: skin necrosis, sloughing, pelvic perineal infection, nerve injury. Long term complications studied include: claudication, skin ulceration, regional pain.
242
Global indications for post traumatic embolizations?
1) Active arterial extravasation. 2) Vascular injury (ie. pseudoaneurysm, AVF). 3) High grade organ injury with decreasing H/H.
243
When would a hemodynamically unstable patient be taken to angiography for embolization?
In the setting of a pelvic fractures without a clear abdominal source for the bleed as deep pelvic bleeding is difficult to localize in the OR.
244
Hepatic Embolization. 1) What type of embolics are used in the setting of liver trauma? 2) If multiple vessels are injured, which embolic is used? 3) How is a pseudoaneurysm embolized? 4) Should a psuedoaneurysm be packed with coils? Why? 5) What are the complications of hepatic artery embolization?
1) Coils, gel foam or glue. 2) Proximal gel foam embolization, especially in unstable patients. 3) Proximal and distal to the PA. 4) No. Increased pressure can lead to rupture. 5) Re-bleeding, infarction (rare in setting of patent portal vein), infection/abscesses, biliary/GB necrosis.
245
What are the most common arteries injured following pelvic trauma?
The posterior branches and the two terminal branches of the anterior IIA. In descending order: - Superior gluteal, - Internal pudendal, - Lateral sacral, - Iliolumbar, - Inferior gluteal arteries.
246
The pelvis has various collateral arterial pathways. Knowledge of these pathways is imperative to effectively manage hemorrhage that results from trauma. What are the main arterial stems that can potentially contribute to IIA bleeding?
1) Contralateral IIA 2) IMA 3) Lumbar arteries 4) Median sacral 5) Inferior epigastric (from EIA) 6) Circumflex vessels - medial, lateral and deep (from EIA) 7) Variants
247
What is the Corona Mortis or 'Crown of Death'?
Variant obturator arising from either the EIA, inferior epigastric or CFA.
248
Compliant versus non-compliant balloons?
Compliance: the ability of a structure to stretch or increase in size with increasing pressure. Compliant balloons continue to increase in size with inflations.
249
How can you preserve guidewire access across a contralateral lesion following PTA in order to perform a completion angio?
Inject around a 0.018 guidewire using a Tuohy-Borst adaptor and 0.035-inch lumen guide catheter.
250
Define pseudoaneurysm?
- Contained saccular out pouching of vessel - Equal density to the adjacent vessel - No evidence of extravasation - Washes out on parenchymal phase imaging.
251
1) What are 3 potential causes of a discrepancy between CTA and angiographic findings in the setting of trauma? 2) If active hemorrhage is suspected but not seen on the angio, what are the 2 options?
1) Cessation of bleeding, vasospasm, venous bleed | 2) Provocative angiography with Nitro (OK in trauma b/c short t 1/2 of 3min) OR prophylactically embolize.
252
Embolic agent categories? Subcategories?
Temporary vs. Permanent Mechanical: coils, vascular plugs Particulate agents: PVA, Gelfoam Liquid agents: sclerosants (doxy, bleo), adhesives (glue)
253
When does an artery typically recanalize following Gelfoam occlusion?
2-3 weeks
254
Numerous variations exist in visceral and pelvic vasculature. Which 3 major anomalies are key when searching for angiographic extravasation?
1) Dorsal pancreatic artery arising from the celiac artery in 10%. 2) Replaced RHA from SMA (12%). 3) Corona mortis: obturator from the EIA, inferior epigastric artery (from EIA) or CFA.
255
What are the features of cavernosal blush that allows it to be distinguished from a penile bleed?
1) Midline 2) Below the symphysis 3) Washes out (extrav persists)
256
1) Embolic agents used in renal trauma? | 2) Complications seen post renal embolization?
1) Coils or glue (Get sub-selective) | 2) Infarction, abscess
257
Normal MAP
70 - 105
258
1) Advantages of DEB vs cTACE per the PRECISION V trial.
DEB advantages in the PRECISION trial: - Decreased systemic and hepatic toxicity. - Superior overall response rates and disease control rates in the DEB group though differences not statistically significant. - The improved safety and tolerability profile allowed treatment to be repeated in more advanced cases where cTACE could not. NOTE: A recent case-control study conducted by Song in Asian patients with HCC confirmed higher ORR and DCR for DEB compared with cTACE
259
1) cTACE Steps?
1) Tumor localization with a microcatheter. 2) Pretreatment DP-CBCT (early arterial and delayed phases in a single contrast injection - 5 sec manual delay at start). 3) Infusion: - 50 mg Doxorubicin/10 mg of Mitomycin-C in 10 mL + 10 mL Lipiodol in a 1:1 ratio (total 20 mL) - 20 cc of 1% Lidocaine - 100-300u Embospheres 4) Post treatment SP-CBCT to see distribution of lipiodol.
260
2) DEB Steps?
1) Tumor localization with a microcatheter. 2) Pretreatment DP-CBCT 3) Infusion: 100 mg of Doxorubicin loaded 100-300u beads suspended in contrast (2:1 - 4:1 contrast to DEBs). 4) Post treatment SP-CBCT to see distribution of contrast. NOTE: You can also follow treatment with a DP-CBCT and look for enhancement defects which prove those portions of the tumor were embolized.
261
TACE pretreatment?
- 10 mg Dexamethasone - 50 mg Benadryl - 8 mg Zofran - Antibiotic prophylaxis and PPIs at discretion of MD.
262
1) How is significant arterio-portal or hepatic venous shunting addressed prior to TACE? 2) What if shunt can't be reduced?
1) Gelfoam embolization. | 2) Procedure cannot be performed.
263
1) DEB Infusion rate? 2) DEB injection endpoint? 3) What if the near stasis endpoint is not obtained after injection of the scheduled dose?
1) Slow (some advocate 1 cc DEB/contrast mix/minute. 2) Continue until near stasis in the feeding artery. Contrast column should clear within 2 to 5 heartbeats. 3) Bland embolization until injection end point reached OR schedule patient for repeat treatment.
264
3 scenarios when should TACE be discontinued?
1) Failure to achieve objective response in targeted tumor after two treatments. 2) Clinical deterioration to ECOG > 2 3) Hepatic decompensation (CP B8 or higher).
265
TACE: 5 absolute contraindications?
1) Decompensated cirrhosis - Child-Pugh B8 or higher (jaundice, clinical encephalopathy, refractory ascites, hepatorenal syndrome) 2) Massive tumor replacement of both lobes 3) Severely reduced portal vein flow 4) Untreatable AVF 5) Renal insufficiency (Cr > 2, CrCl < 30)
266
Is there a benefit to combining Sorafenib with DEB and cTACE?
Yes. Studies have shown that time to progression (TTP) for cTACE/DEB plus Sorafenib was longer than the TTP seen in patients treated with TACE and placebo.
267
Anterior Division branches of the Internal Iliac Artery?
Identified based on branching pattern, no course. Three groups: First: - Uterine: desc, trans, ascending (deferential in males) - Superior vesicle: descending only - Obturator artery: thru obturator foramen Mid: - Inferior vesicle artery in males (prostate vessels) versus vaginal in females - Middle rectal artery Terminal branches: - Inferior gluteal artery: exits pelvis via greater sciatic foramen. - Internal pudendal artery: supplies genital branches including the dorsal aa of penis and scrotal vessels. Gives rise to the inferior rectal artery.
268
1) What is the approximate threshold for external beam radiation to the liver? 2) What type of radiation does Y90 emit? 3) What is the mean tissue penetration? Does this influence dosing? 4) What is the radiation dose required to destroy solid tumors?
1) Doses in excess of 30 Gy can be toxic to adjacent liver parenchyma. 2) Pure B-emitter. 3) 2.5 mm (11 mm max). Yes, permits higher dosing of 100-150 Gy. 4) >70 Gy
269
SIR-Spheres vs. TheraSpheres: - Composition? - Approved use? - Sphere diameter? - Dose/sphere? What must be considered during the administration of SirSpheres given their lower per sphere dosage?
``` SIR-Spheres (SRC-50): Composition: Resin Approved use: Colorectal mets Sphere diameter: 22u Dose/sphere: 50 Bq ``` ``` TheraSpheres: Composition: Glass Approved use: Unresectable HCC Sphere diameter: 32u Dose/sphere: 2500 Bq ``` Given the smaller per-sphere dose of SIR-Spheres, a significantly larger number of spheres must be administered to reach the intended dose. It is not uncommon for the entire vascular bed to become saturated with microspheres and an embolic state reached prior to delivering the entire dose. This also increases the risk of reflux, requiring prophylactic embolization of the RGA/GDA.
270
Significant radiation pneumonitis during Y90 is possible at what threshold dose? What is the lifetime lung exposure limit?
>30 Gy 50 Gy
271
1) How is a shunt study performed?
- Aortogram - SMA angio w/ portal eval - Celiac angio - Prophylactic vessel embo (GDA/RGA) w/ SIR - 5 mCi Tc99m MAA administered into the vessel being treated (image within 1 h) NOTE: Unilobar or whole liver injection of MAA may be performed. Irrespective of the location of MAA injection, it is imperative that the MAA be delivered with flow rates and catheter position that mimic the anticipated Y90 infusion rate.
272
Y90 whole liver treatment nomenclature: 1) What is "Whole liver delivery" vs "Sequential or lobar delivery"? 2) What is the ideal interval between treatments?
"Whole liver delivery": treating both lobes in one setting vs "Sequential or lobar delivery": treating one lobe, then the other after a 4-6 week interval.
273
Y90 Side effects 1) Are they more severe than those seen with TACE? 2) Name 5 side effects?
1) Least intense of all the intra-arterial loco-regional therapy options. 2) Side effects: - Fatigue and abdominal pain (seen in 25%) - Radiation pneumonitis (at doses > 30 Gy) - Radiation gastritis (<8%) - GB wall edema not requiring cholecystectomy - RILD (Radiation induced liver disease)
274
4 absolute contraindications to Y90.
1) Pretreatment MAA scan demonstrating >30 Gy radiation exposure to the lung. Lifetime limit 50 Gy. 2) Pretreatment MAA scan demonstrating flow to the GI tract that cannot be corrected by catheter embolization techniques 3) Pregnancy/Breastfeeding 4) Capecitabine therapy
275
Y90 Radiation therapy discharge instructions.
1) Avoid close contact (<1m) with others for one week. 2) 24h fluid precautions with SirSpheres only (double flush, sit to urinate), not with Theraspheres. 3) Patient is able to get urgent medical treatment as needed. Medical staff can contact RSO with questions.
276
CP and ECOG limitations on TACE and Y90.
CP > B-8 is an absolute contraindication. ECOG > 2 is contraindication as progression to liver failure likely. BCLC for TACE says ECOG 0. But patients should be independently assessed. Y90 has less toxicity and may be safer in borderline patients.
277
Trials
RESILIANT BMS vs. PTA: BMS associated with better angiographic results and improved clinical outcomes compared vs PTA in tx of moderate-length lesions in the SFA and proximal popliteal artery. VIASTAR GRAFT vs. BMS Fempop: SE heparin bonded Stent Grafts better than BMS in tx of long fem-pop lesions. COBEST GRAFT vs. BMS Aortoiliac: SE covered stents better than BMS in tx of Aortoiliac dz. ATTRACT PTS at 2Y POST DVT: Looking at PTS rates post LE DVT in patients randomized to AC alone or AC in combo with pharmachomechanical thrombolysis. INPACT SFA Trial DCB vs. PTA: Compared the InPact DCB (Paclitaxel) to standard PTA. DCB REQUIRED fewer TLRs vs PTA and demonstrated better primary patency at 12m (82% vs 52% w PTA) ZILVER PTX DES vs. BMS: DES (Paclitaxel) superior to BMS with respect to patency and freedom from TLR. BASIL BYPASS vs. PTA: Bypass-surgery vs PTA in patients with severe infrainguinal ischemic disease. Short-term: surgery is more expensive and has higher morbidity. Medium term: outcomes similar with respect to amputation-free survival, all-cause mortality and HRQL. Long term (>2y): surgery may be more durable.
278
Trans Atlantic Inter-Society Consensus (TASC II) classification 1) What is it? 2) What are the classes? 3) What are the treatments for each class?
1) Classification scheme for describing atherosclerotic disease patterns in the lower extremities. Based on anatomic distribution, # of lesions and lesion characteristics (stenosis, occlusion). 2) A-D, describing Aortoiliac and Fempop disease patterns. None define tibial disease. Type A lesions: Aortoiliac: - Short CIA or EIA stenoses (≤3 cm) Femoropopliteal: - Single stenosis ≤10 cm or single occlusion ≤5 cm Type B lesions: Aortoiliac: - Short (≤3 cm) stenosis of the infrarenal aorta - UL CIA occlusion - Single or multiple EIA stenoses (3-10 cm) not involving the CFA - UL EIA occlusion not involving the origins of the IIA or CFA Femoropopliteal: - Multiple stenoses or occlusions, each ≤5 cm - Stenosis or occlusion ≤15 cm not involving the infra-geniculate popliteal artery - Single or multiple lesions in the absence of continuous tibial vessels to improve inflow for a distal bypass - Heavily calcified occlusion ≤5 cm - Single popliteal stenosis Type C lesions: Aortoiliac: - BL CIA occlusions - BL EIA stenosis (3-10 cm) not involving the CFA - UL EIA stenosis extending into the CFA - UL EIA occlusion involving the origin of the IIA or CFA - Heavily calcified UL EAI occlusion with or without involvement of the origins of the IIA or CFA Femoropopliteal: - Multiple stenoses or occlusion totaling >15 cm (+/-) heavy calcification - Recurrent stenoses/occlusion post two endovascular interventions Type D lesions: Aortoiliac: - Infrarenal aortoiliac occlusion - Diffuse disease of the aorta and both iliac arteries - Diffuse multiple stenoses involving the UL CIA, EIA and CFA - UL occlusions of both the CIA and EIA - BL occlusions of EIA - Iliac stenoses in patients with AAA not amenable to endograft placement Femoropopliteal: - CTO of the CFA or SFA (>20 cm, involving the popliteal artery) - CTO of the popliteal artery and proximal trifurcation vessels 3) Outcomes data recommends endovascular for A & B, surgical for C & D.
279
Strategies for accessing a non-dilated collecting system?
1) IV furosemide and a 250 mL normal saline bolus to temporary dilate calyces for US guided access. 2) Administration of 50-80 cc IV contrast to opacify the renal collecting system for fluoroscopically guided calyceal access. Note contrast will wash out quickly so many use contrast for the two-stick technique. 3) Two-stick technique (with or with our IV contrast). 4) Combined procedure with retrograde ureterography.
280
What are the steps involved in the 2 stick percutaneous nephrostomy technique?
Two-stick technique: 1) 21G needle is placed directly into the renal pelvis from a straight PA approach. 50-80 cc IV contrast can be used to guide initial needle placement. Alternatively, fluoroscopic guidance can be based on the renal shadow or osseous landmarks (2 cm lateral to transverse process of L2). If no urine is aspirated after the first needle pass, change the approach angle by 10 degrees in one direction or another (operator choice). NOTE: After administration of IV contrast, using a straight PA approach, the posterior calyces are typically seen en face, whereas the anterior calyces are visualized longitudinally. 2) Once access is obtained in the renal pelvis, 10 cc of 50% contrast is injected to confirm adequate placement of the renal pelvis needle. 3) Air is then injected while watching under fluoroscopy. Gas will rise to the nondependent calyces, in which a prone patient is the posterior calyces complex. This represents the target calyx for puncture. You must watch or you will be unable to distinguish the air from bowel gas. 4) Once the appropriate posterior calyx is identified, chose an exit site (hands breadth medial to the posterior axillary line). Place hemostat at the exit site and angle the X-ray tube in both the mediolateral and craniocaudal projection allowing superimposition of the hemostat and the targeted calyx, facilitating a “down the barrel” approach for the catheter placement. 5) Once the calyx is accessed, standard technique is performed for final tube placement.
281
1) What drug is used for opioid reversal? | 2) What is the dose?
1) Naloxone | 2) 0.1–0.2 mg slow IVP at 2–3-minute intervals until desired degree of reversal is achieved. 

282
1) What drug is used for BZD reversal? | 2) What is the dose?
1) Flumazenil | 2) 200ug over 15 seconds. Repeated doses may be necessary; maximum total dose 
is 3 mg.
283
1) What drugs are used to reverse INR? 2) Which is the most rapid acting? How long does it last? What is the minimum dose that is usually required? 3) How long does it take for VK to work? 4) Should VK be given to patients on Warfarin with an elevated INR?
1) VK (used in patients with synthetic liver dysfuntion) and FFP 2) FFP: Used for transient reversal of warfarin. Lasts six hours. A minimum dose of at least 2 units is usually required with one of the units given at the start of the procedure. 3) 12h 4) Following VK, it may take 2–3 weeks to reestablish anticoagulation with warfarin. Do not use vitamin K1 when continued anticoagulation is desired!
284
1) What does 1% imply in 1% Lidocaine? What is the maximum amount of 1% Lidocaine that should be administered? 2) What local anesthetic can be given in the setting of a lidocaine allergy? 3) Which local anaesthetic is long acting?
1) 1% contains 10 mg/mL. Do not exceed 20 mL or 200 mg. 2% contains 20 mg/mL (do not exceed 10 mL). 2) 1% Prilocaine (can give up to 40 mL or 400 mg. 3) Bupivacaine: Not used for induction because it takes up to 30 minutes to reach full effect. And Ropivocaine.
285
1) What are the starting doses of morphine? | 2) How long does it last?
1) 1 mg in elderly, 2.5 mg in normal adult. | 2) 4–6 hours.
286
1) What is the dose of Atropine used in the treatment of bradycardia? Max dose? 2) What are the side effects? 3) Contraindications?
1) 0.6 mg IVP. Max dose 3 mg. 2) Dose-related anticholinergic effects: dry mouth, urinary retention, blurred vision. 3) Closed angle glaucoma.
287
What drugs can be used to manage hypertension in inpatients (GOAL ≤160/≤100 mmHg)
- Hydralazine - Labetalol - Enalaprilat (IV Enalapril) - Oral clonidine - Oral captopril - Nifedipine (AVOID) Hydralazine: Initial dose 10 mg IV, with max dose 20 mg IV. Labetalol: - PO: 100 mg po bid - IVP: bolus 20 mg initially, followed by 20 to 80 mg q10m to a total dose of 300 mg. - Infusion: 0.5 to 2 mg/min Enalaprilat: 0.625 mg IV initial dose (up to 5 mg q6h). 1.25 mg IV equal to 5 mg PO. Can elicit hypotensive response hypovolemic patients with high plasma renin. Oral clonidine: 0.2 mg (not intended as long-term therapy) Oral captopril: 6.25 or 12.5 mg (if the patient is not volume depleted) Nifedipine (CCB): AVOID. There are some issues with the sublingual type.
288
What is the maximum decrease in MAP that should occur in the first few hours following BP correction?
MAP should not decrease by more than 25-30% in first few hours.
289
Bleomycin adhesive precautions?
Avoid adhesives as possible. Allow adhesives and EKG pads to fall off naturally.
290
Antibiotic prophylaxis in IR
Clean: A procedure is regarded as clean if the GI, GU or respiratory tract is not entered, if inflammation is not evident, and if there is no break in aseptic technique. Example: routine diagnostic angiography. Clean-contaminated: A procedure is regarded as clean-contaminated if the GI, biliary, or GU tract is entered but there is no break in aseptic technique. Example: nephrostomy tube placement in a patient with sterile urine. Contaminated: A procedure is regarded as contaminated if there is entry into an inflamed or colonized GI or GU tract without frank pus, or if a major break in aseptic technique occurs. Dirty: A procedure is regarded as dirty if it involves entering an infected purulent site such as an ab- scess, a clinically infected biliary or GU site, or perforated viscus. Antibiotic prophylaxis for IR procedures is generally recommended for procedures that are not clean, or for procedures that are considered clean but, as a result of which, a potentially significant volume of necrotic tissue is generated in potentially contaminated areas, eg, embolization with intent to create infarction.
291
Cases for which Abx prophylaxis is recommended?
Antibiotic prophylaxis for IR procedures is generally recommended for procedures that are not clean, or for procedures that are considered clean but, as a result of which, a potentially significant volume of necrotic tissue is generated in potentially contaminated areas, eg, embolization with intent to create infarction. ``` Aortic eddografts Peripheral endografts Dialysis access endografts Ports in IC pts Embolization/chemoembolization (2/2 infarction) UFE (2/2 infarction) PEG (pull technique, not push; check JHH) Biliary drainage (1 gm Ceftriaxone: 3G w enhanced biliary excretion vs 2G Cefotetan) Percutaneous Nephrostomy Tube Placement Tube Exchange (only if infected) Ureteral Stents Percutaneous abscess drainage Verteboplasty/Kyphoplasty ```
292
T/F: Bilioenteric anastomoses increase the risk of hepatic infection following interventional procedures?
True
293
What are some of the indications for partial splenic artery embolization?
Trauma, portal HTN complications, and hypersplenism (plt < 75K) due to various etiologies
294
How much do platelet values increase after partial splenic artery embolization?
To levels above 100K
295
Are antibiotic prophylaxis and vaccinations appropriate pre procedure given the risk of post procedure infections?
Yes (pneumococcal, H influenza & meningococcal vaccine).
296
Which splenic vessels should be targeted initially in partial splenic artery embolization? Why?
The middle or lower pole splenic branches due to lower risk of pain and pulmonary complications such as atelectasis, pneumonia and pleural effusion which are more common with upper lobe embolization.
297
What embolization agents are used in partial splenic artery embolization?
Embospheres (300-500 & 500-700 μm). It can be mixed with 80 mg of gentamycin and injected slowly. Other agents include Gelfoam, nBCA and coils.
298
1) How much spleen should be embolized during the initial partial SAE procedure? Lifetime? 2) Post embolization splenic abscess risk and the risk of bacterial peritonitis increase the most above what embolization percentage?
1) 30% to 40% (lifetime 70%) | 2) 70%
299
When can a second partial spelnic artery embolization occur?
After 1 month if adequate therapeutic response has not been achieved.
300
1) Post procedure care following partial spelnic artery embolization? 2) What is the antibiotic regimen used post partial splenic artery embolization? 3) When is the initial post procedure CT preformed after partial splenic artery embolization?
1) Admit patients for management of postembolization syndrome (fever, LUQ pain, NV, anorexia) and PCA. 2) Antibiotic prophylaxis with 250 to 500 mg per day of amoxicillin x 10d OR 1 gm Cefaperazone q12h x 5d OR suspend beads in Gentamycin. 3) CTAP with contrast after one day to evaluate extent of infarction.
301
IVC Filter minimum caval size?
13 mm
302
Strategies for replacing an irreversibly blocked pigtail?
If the drain has been in for > 1 week, the tract is well-established. The catheter can be removed, a hydrophilic guidewire can be passed into the collection and a new drain can be placed over the wire. Alternatively, cut the hub off the catheter, pass a sheath over the outside of the catheter, remove the catheter, pass a guidewire into the collection through the sheath, then remove the sheath and place a new catheter over the wire.
303
Approach for draining perirectal collections?
Posterior transgluteal route traversing the sacrosciatic notch. The sciatic nerve and gluteal vessels pass through the anterior portion of the notch. To avoid them, the tract should pass as close to the sacrum as possible.
304
ULTIMA Trial: The Ultrasound Accelerated Thrombolysis of Pulmonary Embolism trial investigated whether a standardized fixed-dose Ultrasound-assisted catheter-directed thrombolysis (USAT) regimen is superior to anticoagulation alone in the reversal of RV dilatation in intermediate-risk PE patients (RV dysfunction without hypotension). USAT regimen superior to heparin alone in reversing RV dilatation at 24 hours. No increase in bleeding complications. There was also a statically significant decrease in right heart pressures in the USAT group.
USAT regimen superior to heparin alone in reversing RV dilatation at 24 hours. No increase in bleeding complications. There was also a statically significant decrease in right heart pressures in the USAT group.
305
The Pulmonary Embolism Thrombolysis (PEITHO) trial Compared tenecteplase (30-50 mg bolus) plus heparin with placebo plus heparin in patients with intermediate-risk pulmonary embolism (RV dysfunction without hypotension). Primary outcome: death or hemodynamic decompensation within 7 days after randomization. Main safety outcomes: major extracranial bleeding and ischemic or hemorrhagic stroke within 7 days after randomization.
In patients with intermediate-risk pulmonary embolism, fibrinolytic therapy prevented hemodynamic decompensation but increased the risk of major hemorrhage (11.5% vs. 2.4%) and stroke (2.4% vs. 0.2%).
306
SI Joints: Upper 2/3 is the .... portion? Lower 1/3 is the .... portion?
Upper 2/3 is the LIGAMENTOUS portion? Lower 1/3 is the SYNOVIAL portion lined by hyaline cartilage?
307
Spinal infiltration injection volumes Epidural blocks: CS & LS? Nerve root blocks? Facet joints?
Epidural blocks: 3-10 ml (LS) 3-6.5 (CS) Nerve root blocks: 2-4 ml (0.5 cc Depo-Medrol [40 mg/ml] & 1 cc 0.25% Bupivicaine) Facet joints: 1–2 ml (0.5 cc Depo-Medrol [40 mg/ml] & 1 cc 0.25% Bupivicaine)
308
Is GDA and RGA embolization required prior to Therasphere treatment? Why?
No. Because saturation is less likely to occur given the higher per bead dose.
309
How does PVA come? How is PVA sized? What is the downside to PVA?
Comes in 200u increments (ie. 100-300u) as a dry plastic and is mixed with contrast prior to administering. Use one class smaller versus the Embospheres you would normally use. So if Embospheres were 300-500, you would use 100-300 PVA. Clumping and size irregularity with the potential to occlude more proximally then expected.
310
Does early angio for grade 4/5 hepatic laceratioms decrease patient mortality?
Yes.
311
Endoleaks?
Type I: around the graft anchorage points (not a snug fit!). • Type II: via collateral vessels, lumbar arteries and IMA. • Type III: limb dislocation. Insert another limb to bridge the gap. • Type IV: leakage through the graft material due to porosity; this will settle when the heparin wears off.
312
ACEi contraindications?
- Pregnancy - Severe renal artery stenosis - Severe hyperkalemia
313
Femoral artery divisions?
``` Common femoral - Femoral (more medial) - Profunda - Medial & Lateral Circumflex (asc/desc branches) ```
314
Sheathes: Ansel Destination
Ansel 1, 2 and 3: each have a curved tip curved tip with the angle becoming more acute from 1 to 3. Ansel also makes a straight tip. Destination: various shapes (RDC has 2 curves; also available as straight tip, hockey stick etc).
315
Bronchial artery embolization steps?
1) RCFA Access 2) 5 Fr sheath 3) Omniflush aortogram from arch 4) 5 Fr Mickleson, SOS Select, non-glide C2, Sim1 to select bronchials (anterolateral at level of carina) with contrast limit of 5 cc/kg. 5) Renegade high flow and .016 Fathom to achieve purchase in bronchials. 6) Embolize with 0.2cc alloquats of Embospheres (>250u decreases risk of tissue necrosis and spinal artery delivery). Follow with slow saline flush to push beads out of catheter.
316
NUS Steps?
- 21g needle access - Contrast to confirm position - Mandrel wire - Aprima set (remove inner metal once accessed) - 4 Fr tapered glide cath and glide wire to access bladder. - Measure from UVJ to renal pelvis with glide to determine NUS length leaving catheter in bladder. - Amplatz through catheter into bladder. - NUS over Amplatz
317
Varicocele/Pelvic congestion - steps?
- 5 Fr Micropuncture - 9 Fr 11 cm Vascular sheath - 8 Fr Hopkins Hook to select LRV and LGV - 5 Fr 100 cm glide JB1 catheter and Bentson wire to get down the LGV (or 6 Fr MPC if >= 1cm plug to be used) - Regular Renegade and 0.018 shapeable straight tip GT for coiling (above inguinal ligament) - Sim1 or 2 formed in LRV through Hopkins Hook then used to select RGV Pelvic congestion can be checked post embolization by using the Hopkins catheter and JB1 to select the left internal iliac vein and perform venography with and without balloon occlusion with Behrman wedge. The right internal iliac vein can be selected with the Sim 2.
318
Ufe
A
319
Curacao criteria?
The Curacao criteria, published in 2000, remain the mainstay of HHT clinical diagnosis: - Recurrent, spontaneous nosebleeds - Mucocutaneous telangiectases at characteristic sites (fingertips, lips, oral mucosa, tongue) - Visceral AVMs (gastrointestinal, pulmonary, hepatic, cerebral, or spinal) - Family history (first-degree affected relative)
320
1) How is Sotradecol prepared for use during gonadal vein embolization? 2) What is the sandwich technique?
1) Sotradecol foam preparation of 1 mL 3% STS mixed with 4 mL of air (improves endothelial surface contact, slows or stops flow allowing for extended periods of contact). Foam injected while withdrawing catheter. Dose avg 0.5 - 2 ml (up to 6 ml use reported). 2) Sandwhich technique: coil-Sotradecol-coil (first coil pack just above inguinal ligament).
321
Amplatzer plugs: A 5 Fr catheter can accommodate up to what size plug?
8 mm; 1 cm plugs require a 6 Fr catheter.
322
Abdominal pleurex placement?
- Incision sites in RUQ below costochondrol jx - Introducer and wire inserted at oblique angle - Anesthetize 5-8 cm track - Tunnel so cuff is 1 cm from superior incision - Insert peel away then remove wire and insert catheter
323
T/F: 90% of biliary strictures are malignant?
True
324
Which biliary ducts occupy the left hepatic lobe? Which should be accessed?
Dorsal and ventral ducts. The ventral duct which is oriented towards the skin surface is accessed subxiphoid.
325
Lipiodol limit during TACE case?
20 cc
326
Which projection opens the biliary tree?
LAO
327
When should new PTC be changed?
6-8 weeks
328
Intubation period for PTC placed for benign stricture? 1y patency following clinical trial and Whittaker.
3-6m, followed by 2w clinical trial (cut short) and Whittaker? 90% 1y patency with clinical trial and Whittaker vs. 70% with just clinical trial.
329
Transjugular liver biopsy steps?
- Bentson - 9 Fr sheath - Inter abdominal IVC, intra IVC, and RA pressure - 5 Fr curved tip catheter (MPA) to select RHV - Lateral - Behrmann over a Rosen - Free, retired and wedges pressure - Sheath advanced over Rosen and Behrmann - Rosen and Behrmann out - Biopsy introducer in so it just pokes out tip of sheath - Torque anterior - Advance needle to black line - Push cocked needle forward and sample - Venography post bx to r/o leak
330
Are all adrenal biopsy patients premedicated with somatostatin?
No, unless there are signs and sxs of pheochromocytoma or biochemical abnormalities.
331
IVC Filter Removal Steps for Celect and Denali?
Celect: - 9 Fr 45 cm sheath over Bentson - 5 Fr flush run below filter - 15 mm gooseneck snare of filter hook - 9 Fr sheath down over top of filter Denali: - 11 Fr 35 cm sheath over Bentson - 5 Fr flush run below filter - 9 Fr 45 cm sheath through 11 - 15 mm gooseneck snare of filter hook - 9 Fr sheath down over filter to leg hooks - Sheath filter with 9 Fr - Once filter covered pull up through 11 Fr
332
Complicated IVC filter removal techniques?
Loop snare technique using a revere curve catheter to displace embedded hook on tilted filter. Balloon displacement technique to displace penetrating filter strut. Endobronchial forceps technique to grasp embedded filter hook.
333
Algorithm for determining most appropriate DVT treatment?
1) Age of thrombus: acute/subacute (4w). 2) Extent of thrombus: if all infrainguinal, US imaging sufficient; if BL leg involvement, then pelvic vein or IVC is involved and CTV or MRV needed. 3) Co-morbidities: renal insufficiency, contraindications to thrombolysis, contrast allergies, thrombocytopenia, coagulopathies.
334
Rapid Lysis Technique?
1) Popliteal access 2) Initial venogram 3) Cross the clot all the way to central aspect 4) Put in 8 Fr sheath. 5) Coaxially place 8 Fr hockey stick guide catheter, through which we put AngioJet catheter with tPA (10 of tPA in 500 NS or 25 of tPA 1000 NS). Perform the spiraling technique (rotate the guide catheter rather than the AngioJet catheter) while slowly retracting both through the clot burden with the Angiojet vacuum on (vs. Angiojet power-pulse technique where you are pulsing tPA while moving forward thru the clot over a wire, waiting, then withdrawing with vacuum on). Rotating the hockey stick allows for wall to wall circumferential apposition. 6) Treat 10-15 cm segments followed by venography through Angiojet sideport. Then treat more peripheral segment.
335
Afferent limb? Efferent (roux limb)?
Afferent: duodenum and proximal jejunum Efferent (roux limb): from GJ to JJ.
336
TIPSS Flow Parameters
nl PV >30 cm/s TIPS v: 90-190, difference no greater than 100 Fugal in R and L PV towards TIPS
337
Aortic branch levels?
``` T12: Celiac L1: SMA L2: Renals L3: IMA L4: Bifurcation ```
338
TIPSS Flow Parameters
nl PV >30 cm/s TIPS v: 90-190, difference no greater than 100 Fugal in R and L PV towards TIPS
339
Aortic branch levels?
``` T12: Celiac L1: SMA L2: Renals L3: IMA L4: Bifurcation ```
340
Classic Whipple (standard pancreaticoduodenectomy) or the Pylorus Preserving Whipple (pylorus preserving pancreaticoduodenectomy)?
Both variations involve the removal of the gallbladder, CBD, duodenum and head of the pancreas. In the Classic Whipple, a 30-40% distal gastrectomy or stomach resection is preformed. In the pylorus preserving Whipple (Mini-Whipple) the stomach is preserved and the GI tract is transected 1 inch past the stomach leaving a small segment of duodenum. The jejunum gets pulled up and anastamosed to the pancreas (pancreaticojejunostomy) most proximally, then the hepatic duct (hepaticojejunostomy) and then the stomach (gastrojejunostomy).
341
T/F: DEB has less systemic toxicity than cTACE?
True (can be beneficial in cardiac patients)
342
DEB
100 mg in 7 cc Dilute with 3:1 contrast Total volume 28 cc
343
T/F: In the setting of a unilateral kidney obstruction, plasma creatinine concentration is rarely elevated in the setting of a normally functioning contralateral kidney?
True
344
LE Venous Lysis due to clotted IVC Filter
1) Micropuncture access into the popliteal vein. 2) Gentle contrast injection to confirm intraluminal position. 3) 6 Fr sheath 4) Glide wire and glide catheter to access IVC (can periodically check position with gentle contrast admin) 5) Amplatz wire into IVC 6) Unifuse catheter placement with infusion of 0.5 mg tPA hour through each catheter. 7) Sheaths continuously flushed with 1000U Heparin in 500cc saline run at 30cc/hr. 8) After 12 hours, remove occlusion wires and place Amplatz wires through Unifuse catheters. 9) Perform venography through sheaths. 10) 10 tPA in 50 cc saline pulsed using Angiojet from filter to below level of clot (if BL, do 1/2 on each side). Allow to dwell for 20 minutes. 11) Rheolytic thrombectomy from filter to below level of clot. 12) Upsize sheaths as necessary to perform PTA (we used Atlas balloons 12 x 4).
345
Lipiodol mechanism of action?
Scleroses and occludes hepatic arterioles and enters portal venules through AV shunts. This results in reflux of lipiodol into portal veins. We want to see this.
346
Pelvic congestion steps?
L GONADAL - Bentson into IVC - 8 Fr sheath - 7-8 Fr Hopkins Hook pulled down into L renal vein - L Renal Venogram - Push Hopkins forward while injecting contrast and rotating catheter tip towards the anterior and posterior aspects of the vessels. Pull back and push up as needed until catheter seated in L gonadal vein. - L Gonadal Venogram - Glide wire and 5 Fr tapered tip glide catheter to pelvic brim - Pelvic Venogram - note outflow rate, central vein drainage and contrast volume - Sotrodecol foam (1:4 Sotrodecol:air) - Rosen wire through glide catheter to stiffen system. Then advance Hopkins Hook down gonadal to pelvic brim. - Amplatzer plug deployment through HH (plug to tip of HH, then pin and pull until distal plug marker at tip of HH; rotate 6 turns counterclockwise, repeat) R GONADAL - Sim 2 to end of HH in proximal L gonadal vein; pin-pull HH back into IVC, then push up to form Sim (May need to rotate Sim slightly) - Sim 2 to select R Gonadal usually just below R renal. May need to pull down into vessel especially in setting of competent valve. - Repeat above steps on R if necessary. ILIAC - HH to iliac bifurcation - Glide wire and glide catheter into L internal iliac vein - L internal iliac Venogram - Balloon occlusion when........
347
Renal ablation: genitofemoral nerve.
At risk when going through psoas. Patients get thigh numbness. Usually transient.
348
Symptoms post RFA?
DVT < 1% | Nerve injury 2% with 90% resolving
349
T/F? Patients will have benefit from RFA if they have incomplete relief from compression stockings or pain refractory to compression stockings?
True If stockings completely relieve pain, there is no data to show that RFA will benefit, though Heller frequently has seen benefit. May not be able to get insurance to cover this though.
350
Anticoagulatuon with EHIT?
Plavix or Xarelto x 2 weeks
351
When are stockings discontinued after ablation for C2 disease and C4 and above?
C2: discontinue if asx at 2 week visit C4+: continue longer, duration TBD
352
Problem seen post venous ligation?
Vein or branches still fill distally resulting in sx accessory branches.
353
Imaging pelvic vasculature?
Opening FA/SFA: ipsilateral Opening internal/external iliacs: contralateral Opening anterior/posterior branches of iliacs: ipsilateral
354
Abnormal Whittaker pressure?
20 mm Hg
355
Need for compression stockings post GSV ablation?
DC for pts with sx relief and CEAP 2 or less. CEAP 3+ should continue wearing. C2: discontinue if asx at 2 week visit C4+: continue longer, duration TBD
356
Type 1-6 closure levels
Level 1: closure with thrombus below the level of the epigastric vein. Level 2: closure with thrombus extension flush with the orifice of the epigastric vein. Level 3: closure with thrombus extension flush with the saphenofemoral junction. Level 4: closure with thrombus bulging into the common femoral vein (CFV). Level 5: closure with proximal thrombus extension adherent to the adjacent wall of the CFV past the saphenofemoral junction (SFJ). Level 6: closure with proximal thrombus extension into the CFV, consistent with a DVT.
357
UFE embolic particle size? Consequences of using too small or too large particles?
Perifibroid plexus: ~500u in diameter. Use of particles
358
Treatment algorithms based on GSV closure levels?
Duplex US performed 48-72h postprocedure after removal of all dressings. No further dressing was used in most patients. If US abnormal (level 3-6), treatment was initiated and repeat duplex US performed weekly until the thrombus retracted and stabilized at a level 2 to 3. No further imaging was performed after this finding and discontinuation of anticoagulation. Management of levels of closure: Patients with level 1 or 2 closure 48 to 72 hours postprocedure had no further management of their GSV, although they were instructed to return for a final evaluation of their venous disease 6 weeks postprocedure. Patients with level 3 closure were managed with both observation and repeat duplex ultrasound to assess for progression of thrombus, or with low molecular weight heparin (LMWH) as an outpatient. The LMWH was discontinued when the thrombus had retracted to a level 2 or 3. No further anticoagulation was recommended or used. Patients with level 4 closures were treated with LMWH uniformly, until the thrombus retracted flush with or into the saphenous vein. No further anticoagulation was used after clot retraction. Patients with level 5 closures were treated with outpatient LMWH, which was used until the thrombus retracted to level 3 and then discontinued. Although no patient had a level 6 closure, it would have been treated with LMWH and coumadin for 3 months.
359
Do asymptomatic patients with varicose veins get stockings?
No. No symptoms, no stocking.
360
Can spider veins worsen post sclerosis? Can compression devices cause paradoxical worsening of spiders post sclerosis?
Yes. Yes.
361
GSV Ablation follow up?
72h post op US and appt w nurse 1-2w post w doc Compression stockings: - C2: discontinue if asx at 2 week visit - C4+: continue longer, duration TBD
362
Primary risks assoc with GSV ablation?
< 0.5% PE < 1% DVT 2% nerve injury
363
Walking instructions post GSV ablation?
Walk for 5 minutes every hour post op
364
GREAT PANCREATIC ARTERY | pancreatica magna
One of the largest branches of the splenic artery Chief blood supply of the distal body and tail of the pancreas. If this artery is singular, it usually arises from the midportion of the splenic artery.67 Van Damme and Bonte68 described in detail the confusion involved in the naming of the arteries which supply the bod
365
Acetabular fractures. Fractures involving the anterior column disrupt or displace the ________ line. Posterior column fractures disrupt the __________ line.
Iliopubic Ilioischial
366
Because LC forces reduce the pelvic volume, these injuries are not usually associated with severe bleeding, in contrast to in- juries that increase pelvic volume, such as open book pelvis and vertical shearing injuries.
True
367
Extraperitoneal rupture is more common than intraperitoneal bladder ruptures and is treated conservatively with a Foley placement?
True Extraperitoneal rupture is more common (85% of major bladder injuries) and can usually be managed nonoperatively with Foley catheter drainage. Intraperitoneal bladder ruptures must be repaired surgically.
368
Retrograde cystography was, until recently, the standard diagnostic test. The bladder is filled with 250–300 mL of water- soluble contrast material. When a urethral injury is suspected, a retrograde urethro- gram should be performed prior to Foley catheter insertion
Retrograde cystography was, until recently, the standard diagnostic test. The bladder is filled with 250–300 mL of water- soluble contrast material. When a urethral injury is suspected, a retrograde urethro- gram should be performed prior to Foley catheter insertion
369
CT cystography entails repeating the pelvic CT after a delay of 5–7 minutes to allow filling of the bladder with contrast (the Foley catheter, if present, should be clamped). Alternatively, 250–300 mL of contrast can be instilled into the bladder through the Foley catheter. (Standard abdominal CT is performed 90 seconds after the start of the intravenous contrast bolus and contrast is not present in the urinary tract or bladder.)
CT cystography entails repeating the pelvic CT after a delay of 5–7 minutes to allow filling of the bladder with contrast (the Foley catheter, if present, should be clamped). Alternatively, 250–300 mL of contrast can be instilled into the bladder through the Foley catheter. (Standard abdominal CT is performed 90 seconds after the start of the intravenous contrast bolus and contrast is not present in the urinary tract or bladder.)
370
Therapeutic hip injection meds?
10 mL total 8 mL Bupivicaine 0.25% 2 mL Kenalog 40 (40 mg/mL - total dose 80 mg)
371
Sorafenib MOA
Kinase inhibitor | Inhibits angiogenesis which is increased in setting of tumor hypoxia which occurs post TAE
372
RECIST Criteria?
Looks at maximum dimension of lesion to assess treatment response. Single lesion: multiply the longest diameter by the greatest perpendicular diameter Multiple lesions: sum the products of all measured lesions Complete Response: Disappearance of all lesions Partial Response: >30% decrease Stable: No change Progression: > 20% increase
373
Why need for mRECIST? And what is it?
RECIST criteria does not accurately assess anti-tumor therapies which do not result in tumor shrinkage but rather influence tumor enhancement. mRECIST looks at maximum dimension of lesion to assess treatment response Complete Response: Absent intratumoral arterial enhancement Partial Response: >30% decrease in viable enhancing tumor Stable: No change Progression: > 20% increase in viable enhancing tumor
374
Pulmonary artery thrombolysis
Deploy IVC Filter Short 6 Fr sheath into RIJV 6 Fr Berman catheter was advanced through the sheath RA and RV Pressures Berman to MPA MPA pressure Berman to RPA Rosen into RPA 136 cm EKOS into RPA Second access into RIJV 6 Fr sheath placed 6 Fr Berman advanced into MPA and LPA selected with glide wire Glide exchanged for Rosen 106 cm EKOS into LPA EKOS catheters secured to sheaths using silk and sheaths secured to pt using nylon Pressures: RA, RV, PA, BP Drip Rates: TPA: 0.5 mg/hour through the EKOS port marked “DRUGS”. NS: 35 cc/hour through the EKOS port marked “COOLANT”. Low dose heparin continuous infusion should be initiated through a peripheral IV with goal aPPT of 50- 65 units.
 SHEATH: Heparinized saline: 1000U in 500 ml at 25 ml/hr Fibrinogen levels q4h:
375
Indications for renal artery stenting
Uncontrolled HTN despite 3 meds Flash pulmonary edema or recurrent CHF Loss of renal function or renal mass while on antihypertensives Hypertension with unexplained unilateral small kidney